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PNS - Paranasal sinus 
UDC - Undifferentiated carcinoma 
SNUC- Sino nasal undifferentiated carcinoma 
SNEC- Sino nasal neuroendocrine carcinoma 
SNUC with focal NE - Sinonasal undifferentiated carcinoma with focal  
           Neuroendocrine differentiation.  
SRCT- Small round cell tumor 
PNET- Primitive neuroectodermal tumor 
ONB- Olfactory neuroblastoma  
ITAC- Intestinal type adenocarcinoma 
MEC- Mucoepidermoid carcinoma 
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INTRODUCTION 
 
 
 
 
 
 
 
  
INTRODUCTION 
 
 
The nasal cavity and paranasal sinuses including the maxillary, ethmoid, 
sphenoid and frontal sinuses are collectively referred to as the sinonasal tract. The 
sinonasal tract is anatomically and embryologically distinct from the nasopharynx. 
Although the sinonasal tract and nasopharynx have identical appearing ciliated 
respiratory epithelium, the epithelium of the sinonasal tract is ectodermally derived, 
while that of nasopharynx is endodermally derived. This embryologic difference may 
be a factor in the development of certain epithelial lesions unique to these surfaces 
eg.schneiderian papillomas of sinonasal tract and nasopharyngeal carcinomas.
7 
 
The mucosa of the nasal cavity and paranasal sinuses is often referred to as 
schneiderian mucosa to emphasize its ectodermal origin as opposed to the endodermal 
origin of the morphologically identical mucosa lining the rest of the respiratory tract. 
Nasal stroma is well vascularised fibromuscular tissue. This is occasionally 
misinterpreted as a vascular malformation or a vascular tumour. In the paranasal 
sinuses a layer of thin cancellous bone supports this mucosal and stromal  
arrangement.
8
 
 
The nasal cavity and paranasal sinuses are exposed to a variety of infections, 
chemically irritating, antigenically stimulating, mechanical and traumatic influences. 
As a consequence of these exposures, there are formations of tumor like and truly 
neoplastic conditions.
9
 
1
  
Although the nasal cavity and paranasal sinuses occupy a relatively small 
anatomic space, they are the site of origin of some of the more complex histologically 
diverse group of tumors of the entire human body. 
 
These include neoplasms derived from mucosal epithelium, seromucinous 
glands, soft tissues, bone, cartilage, neural/neuroectodermal tissues, hematolymphoid 
cells and the odontogenic apparatus. Many of the tumours are similar to those found 
elsewhere in the body but a few such as olfactory neuroblastoma are unique to this 
site.
6 
 
Clinically sometimes it becomes quite impossible to distinguish between 
inflammatory conditions presenting as simple polyps, polypoidal lesions due to 
specific disease and polypoidal neoplasms including benign and malignant. For this 
reason it becomes important that all polyps and polypoidal lesions should be 
submitted for histopathological examination.
9   
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AIMS   AND OBJECTIVES 
 
 
 
 
 
 
 
AIMS AND OBJECTIVES 
 
 
1. To study the incidence of sino nasal tumors. 
2. To analyse the age, sex and site distribution of various sino nasal tumors. 
3. To analyse the histopathological types of sino nasal tumors.  
4. To apply immunohistochemistry for cases with uncertain histologic diagnosis. 
3
  
 
 
 
 
 
 
 
 
 
REVIEW   OF LITERATURE 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
 
ANATOMY OF NASAL CAVITY AND PARANASAL SINUSES 
1, 2, 3 
 
 
NASAL CAVITY: Nasal cavity is divided into right and left halves by the nasal 
septum. These two halves open on the face through nares (or) nostril and 
communicate behind with the nasal part of the pharynx through the posterior nasal 
apertures. 
Each half of the nasal cavity can be described as having floor, roof, a lateral 
wall and a medial wall. Each half of the nasal cavity consists of 3 regions: vestibular, 
olfactory, and respiratory. 
 
NASAL SEPTUM: It is a median osteo cartilaginous partition between the two 
halves of the nasal cavity on each side. It is covered by mucous membrane and forms 
the medial wall of both nasal cavities. It is formed partly by bony, partly by cartilage 
and cuticle part. 
 
LATERAL WALL OF NOSE: The lateral wall of nasal cavity presents three 
elevations formed by the superior, middle and inferior turbinates. Each turbinate is a 
curved part of bone, forming a hollow concave space known as meatus, in which there 
are openings of various paranasal sinus and nasolacrimal duct. 
 
PARANASAL SINUSES: They are bilateral, paired air chambers which 
communicate with the nasal cavity. They are frontal, ethmoid, sphenoid and 
maxillary. Each is lined by mucoperiosteum which extends from the nasal cavity and 
is covered by the ciliated respiratory epithelium. 
4
HISTOLOGY OF NASAL CAVITY AND PARANASAL SINUSES 
4, 5
 
 
Each half of the nasal cavity is divided in to 3 regions. 
 
1) Vestibule: It is lined by stratified squamous epithelium. 
 
2) Respiratory segment: It is lined by a ciliated pseudostratified columnar 
epithelium. The epithelium of respiratory segment is composed of five cell types: 
ciliated cells, goblet cells, brush cells, small granule cells and basal cells. 
3) Olfactory segment: It is lined with specialized olfactory mucosa. The olfactory 
epithelium is tall pseudostratified columnar epithelium and is composed of following 
cell types:1)olfactory cells, bipolar neurons 2)supporting or sustentacular cells 3)basal 
cells 4)brush cells. It lacks goblet cells. 
 Paranasal sinuses: are extensions of the respiratory segment of the nasal cavity and 
are lined by respiratory epithelium. 
 
TUMOURS OF NOSE AND PARANASAL SINUSES 
Tumours of nose and paranasal sinuses were first described by Hippocrates 
(BC 460-370) and Galen (AD 131).
10
  
 
Epidemiology: Malignant tumours of sinonasal tract accounts for 0.2-0.8% of all 
human malignancies and only 3% of malignant tumours of upper aerodigestive tract.
11
 
Watson, in reviewing 26000 cancer admissions at the Memorial hospital in the period 
1928 to 1938, observed that 0.44% of these cases primary cancer of the maxillary 
sinus. 
Sixty percent of sinonasal tumours originate in the maxillary sinus, 20-30% in 
the nasal cavity, 10-15% in the ethmoid sinus, and 1% in sphenoid and frontal 
5
sinuses.
6 
When considering the paranasal sinuses alone, 77% of malignant tumors 
arise in the maxillary sinus, 22% in the ethmoid sinus and 1% in the sphenoid and 
frontal sinuses. Malignant neoplasms of this region may lead to significant morbidity 
and disfigurement.
6
 
The incidence of cancer of the nasal cavities and paranasal sinuses (sinonasal 
cancer) is low in most populations (<1.5/1, 00,000 in men and <1.0/1, 00,000 in 
women).Higher rates are recorded in Japan and certain parts of China and India.
6 
 
Etiology: Although exact etiology of sinus cancer is obscure, there is relationship 
between long standing fistulas and nasal or sinus carcinoma. Frazell (1963), in 
reporting 416 cases, noted that over half of the patients had a history of prior sinus or 
nasal surgery. In 330 cases reported by Larsson and Maatensson (1954), 48 patients 
had histories of repeated surgical operations for sinusitis and nasal polyps. 
 
Miller et al (1971) attempted to link this disease to the Epstein Barr virus. 
There is increased risk in wood workers, nickel industrial workers and refinery 
workers .The increase in risk is strongest for adenocarcinomas.
12
An association has 
been shown between tobacco smoking and sino nasal cancer in particular squamous 
cell carcinoma.
6 
Exposure to thorotrast, a radioactive contrast agent, represents an 
additional risk factor.
6
 
 
About ¼ of the tumours of PNS originate in the bone. Thinness of bony 
partition facilitates spread of malignant tumours to adjacent structures. The surface 
epithelium lining the nasal cavity and sinuses produces the greatest number of 
tumours. The respiratory epithelium produces some unique papillary lesions. 
6
Exophytic fungiform papillomas (Ridolfi et al., Snyder and Perzin, 1972; Lasser et al, 
1976) may arise anywhere but are most common on the septum.Bone destruction may 
occur even though the tumour is histologically benign (Skolnik et al., 1966).Radiation 
may account for a few malignant transformations (Mabery et al., 1965).
13
 
 
Tumor location plays a significant role in differential diagnosis .Tumors in the 
region of cribriform plate and upper nasal cavity suggests diagnosis such as olfactory 
neuroblastoma or meningioma. Inverted schneiderian papilloma occurs predominantly 
along the lateral wall of the nasal cavity or the medial maxillary sinus. In lower 
maxilla,odontogenic lesions should be considered. Fibroosseous lesions are 
considered when a radiodense lesion arises from or follows the contour of bone.
6
 
 
Modern imaging plays a key role in the evaluation of sinonasal tumours by 
clearly delineating the anatomy of the lesion with exact margins, in determination of 
surgical approach, and is an integral part of radiotherapy planning.
6 
Sinonasal tumours 
invade the orbit through the lamina papyracea (or) roof of maxillary sinus, spreads 
intracranially through the roof of ethmoid and cribriform plate.
6
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WHO HISTOLOGICAL CLASSIFICATION OF
 
TUMOURS OF NASAL 
CAVITY AND PARANASAL SINUSES 2005
6
 
 
EPITHELIAL TUMOURS:        
         A.Malignant epithelial tumours 
                  1. Squamous cell carcinoma 
                        a.Verrucous squamous cell carcinoma 
                        b.Papillary squamous cell carcinoma 
                        c.Basaloid squamous cell carcinoma. 
                        d.Spindle cell carcinoma. 
                        e.Adenosquamous carcinoma 
                        f.Acantholytic squamous cell carcinoma 
              2. Lymphoepithelial carcinoma 
                  3. Sinonasal undifferentiated carcinoma 
                  4. Adenocarcinoma 
                  5. Salivary gland-type carcinomas                   
                          a.Adenoid cystic carcinoma 
                          b.Acinic cell carcinoma 
                          c.Mucoepidermoid carcinoma 
                          d.Epithelial-myoepithelial carcinoma 
                          e.Clear cell carcinoma  N.O.S 
                          f.Myoepithelial carcinoma 
                            g.Carcinoma ex pleomorphic adenoma 
                          h.Polymorphous low-grade adenocarcinoma 
8
                   6. Neuroendocrine tumours 
                        a.Typical carcinoid 
                        b.Atypical carcinoid 
                        c.Small cell carcinoma, neuroendocrine type 
        B.Benign epithelial tumours                       
                 1. Sinonasal papillomas 
                         a.Inverted papilloma(schneiderian papilloma,Inverted type) 
                         b.Oncocytic papilloma(schneiderian papilloma,oncocytic) 
                         c.Exophytic papilloma(schneiderian papilloma,exophytic)                      
                 2. Salivary gland-type adenomas 
                         a.Pleomorphic adenoma 
                         b.Myoepithelioma 
                         c.Oncocytoma 
SOFT TISSUE TUMOURS            
         A. Malignant tumours 
                         1. Fibrosarcoma 
                         2. Malignant fibrous histiocytoma 
                         3. Leiomyosarcoma 
                         4. Rhabdomyosarcoma 
                         5. Angiosarcoma 
                         6. Malignant peripheral nerve sheath tumours 
          B. Borderline and low malignant tumours 
                      1. Desmoid- type fibromatosis 
                      2. Inflammatory myofibroblastic tumours 
                      3. Glomangiopericytoma (sinonasal –type hemangiopericytoma)                  
9
          C.Benign tumours 
                     1. Myxoma 
                     2. Leiomyoma 
                     3. Haemangioma 
                     4. Schwannoma 
                     5. Neurofibroma 
                     6. Meningioma 
TUMOURS OF BONE AND CARTILAGE 
            A. Malignant tumours 
                     1. Chondrosarcoma 
                     2. Mesenchymal chondrosarcoma 
                     3. Osteosarcoma 
                     4. Chordoma 
            B. Benign tumours 
                     1. Giant cell lesion 
                     2. Giant cell tumour 
                     3. Chondroma 
                     4. Osteoma 
                     5. Chondroblastoma 
                  6. Chondromyxoid fibroma 
                     7. Osteochondroma 
                     8. Osteiod osteoma 
                     9. Osteoblastoma 
                    10. Ameloblastoma 
10
                    11. Nasal chondro mesenchymal hamartoma 
                    12. Ossifying fibroma 
HAEMATOLYMPHOID TUMOURS 
                    1. Extra nodal NK/T cell lymphoma 
                    2. Diffuse large B cell lymphoma 
                    3. Extra medullary plasmacytoma 
                    4. Extra medullary myeloid sarcoma 
                    5. Histiocytic sarcoma 
                    6. Langerhans cell Histiocytosis 
NEUROECTODERMAL                    
                    1. Ewings sarcoma 
                    2. Primitive neuroectodermal tumour 
                    3. Olfactory neuroblastoma 
                    4. Melanotic neuroectodermal tumour of infancy 
                    5. Mucosal malignant melanoma 
GERM CELL TUMOURS 
                  1. Immature teratoma 
                     2. Teratoma with malignant transformation 
                     3. Sinonasal yolk sac tumour(endodermal sinus tumour) 
                     4. Sinonasal teratocarcinosarcoma 
                     5. Mature teratoma 
                     6. Dermoid cyst 
SECONDARY TUMOURS 
11
  
MALIGNANT EPITHELIAL TUMORS 
 
1. SQUAMOUS CELL CARCINOMA
14, 15, 94,95
 
Malignant epithelial neoplasms originating from mucosal epithelium of the 
nasal cavities (or) paranasal sinus includes keratinizing and non-keratinizing types 
of squamous cell carcinoma. They form 3% of malignancies of head and neck. 
Location: 
 Sinonasal squamous cell carcinoma occurs most frequently in the maxillary 
sinus (60-70%) followed by nasal cavity, ethmoid sinus (10-15%) sphenoid and 
frontal sinuses (1%). Squamous cell carcinoma of the nasal vestibule should be 
considered as arising from skin rather than sinonasal mucosal epithelium. 
Macroscopy: 
 Squamous cell carcinoma may be exophytic, fungating, papillary, friable, 
haemorrhagic, indurated or infiltrative. 
Microscopy: 
 The tumor cells are arranged in nests, masses or are scattered individually. 
Histological evidence of squamous differentiation in the form of extra and 
intracellular keratin and intracellular bridges is noted. The carcinoma may be well, 
moderately or poorly differentiated. Most tumors are moderately differentiated 
squamous cell carcinomas
85
.  
Non-keratinising (cylindrical cell, transitional) squamous carcinoma: 
 This distinct tumor of sinonasal tract is characterized by plexiform or 
ribbon like growth pattern. As the name implies keratinisation is absent. 
12
  
Precursor lesions: 
 Precursor lesions for sinonasal tract tumors are less well defined. 
Schneiderian (inverted) papilloma appears to be a precursor lesion with 10% 
frequency of association.
16
 The role of squamous metaplasia as precursor lesion is 
not clearly established. 
 
Prognosis: 
 Patients with nasal squamous cell carcinoma generally present earlier than 
patients with maxillary cancers and have better prognosis than the latter group. 
They rarely metastasize to lymphnodes but show early recurrence. Advanced local 
disease worsens the prognosis. 
 The overall 5 years survival for nasal squamous cell carcinoma is about 
60%. Squamous cell carcinoma of maxillary sinus has a more ominous prognosis 
and it correlates with age. 
 Patients with non-keratinising type of carcinoma tend to do better than 
keratinising type. The overall 5 year survival for maxillary sinus cancer is 42%. 
 
VARIANTS: 
a. Papillary squamous cell carcinoma: 
 It may present as either insitu or invasive tumor. Macroscopically, the 
lesion is composed of exophytic papillary structures covered by epithelium 
showing nuclear pleomorphism, koilocytosis and atypical mitotic figures 
containing cores of fibrovascular stroma
17
.  
 
13
  
b. Basaloid squamous cell carcinoma: 
It is uncommon in sinonasal tract. It is an aggressive variant characterized 
by rounded nests of cytologically highly atypical and mitotically active basaloid 
epithelial cells with high nucleo-cytoplasmic ratio and hyperchromatic nuclei, 
comedo necrosis with focal squamous differentiation
18
. 
 
c. Spindle cell carcinoma: 
 It is characterized by a biphasic pattern of squamous cell carcinoma along 
with much larger component of malignant spindle cells reminiscent of sarcoma. 
Immunohistochemical or ultrastructural evidence of epithelial differentiation is 
required for the diagnosis. The spindle cell component is vimentin positive. 
Keratin positivity is scant and is difficult to demonstrate. 
Other variants include verrucous carcinoma and adenosquamous carcinoma. 
 
2. LYMPHO EPITHELIAL CARCINOMA
6
 
 It is a poorly differentiated squamous cell carcinoma or histologically 
undifferentiated carcinoma accompanied by prominent reactive 
lymphoplasmacytic infiltrate, morphologically similar to nasopharyngeal 
carcinoma with EBV association. They are more common in nasal cavity than in 
paranasal sinuses. 
Histopathology: 
 The tumor infiltrates the mucosa in the form of irregular islands and 
sheets without a desmoplastic stroma. The tumor cells possess relatively 
14
  
monotonous vesicular nucleus and prominent nucleoli. Syncitial or spindled 
morphology may be seen. 
 
3. SINONASAL UNDIFFERENTIATED CARCINOMA
19, 20, 97
 
 Sinonasal undifferentiated carcinoma (SNUC) was originally defined as a 
high grade malignant epithelial neoplasm of the nasal cavity and paranasal sinuses 
of uncertain histogenesis with or without neuroendocrine differentiation but 
without evidence of squamous or glandular differentiation. It is a highly aggressive 
and clinicopathologically distrinct carcinoma of uncertain histogenesis that 
typically presents with locally extensive disease. They are negative for Epstein 
Barr virus by IHC and ISH. 
Clinical Features:  
 A rare tumor, with fewer than 100 reported cases. There is male 
preponderance (2:1 to 3:1). The median age of presentation in the 6
th
 decade. 
SNUCs generally present as large tumors involving multiple (sinonasal tract) sites 
and may also extend into the nasopharynx and adjacent structures including bony 
destruction. 
Microscopy: 
 The cellular infiltrate consists of polygonal cells composed of medium to 
large sized, round to oval, hyperchromatic nuclei, inconspicuous to prominent 
nucleoli, and a varying amount of eosinophilic cytoplasm,mitotic activity and 
necrosis.  
 
 
15
  
Differential diagnosis: 
 Primarily includes poorly differentiated squamous cell carcinoma, high 
grade / poorly differentiated adenocarcinoma, olfactory neuroblastoma (high 
grade), small cell undifferentiated neuroendocrine carcinoma, mucosal malignant 
melanoma, nasal type natural killer (NK) / T-Cell lymphoma and 
rhabdomyosarcoma. Although differences can be seen by light microscopic 
evaluation, often the distinction rests on the immunohistochemical profile for a 
given tumor. 
Immunohistochemistry: 
Immunocytochemical stains for pan-cytokeratin and simple keratins, 
including CK7, CK8, and CK19, are positive in all cases
92
.The tumors are variably 
positive for epithelial membrane antigen, neuron-specific enolase, CD99, p53, and 
p63. The tumors are negative for carcinoembryonic antigen, S-100 protein, 
chromogranin, and synaptophysin.
93
 
 
4. ADENOCARCINOMA 
21, 22
  
Historical aspects: 
 The early literature was deficient in reports of adenocarcinoma in the nasal 
region. Ringertz (1938) found 10 out of 31 glandular tumors involving the nose 
and paranasal sinuses representing less than 4% of all carcinoma in this region. Mc 
Donald and Havens (1948) reported 57 adenocarcinomas out of 95 glandular 
tumors while Spiro, Koss (1973) reported 49 out of 122 glandular tumors. 
 These are glandular malignancies of the sinonasal tract. Two main 
categories (according to WHO)
 6
 are: 
16
  
a. Intestinal type adenocarcinoma. 
b. Non intestinal type adenocarcinoma which is further divided into low grade 
and high grade sub-types. 
The adenocarcinomas and salivary type carcinoma together comprise 10-
20% of all sinonasal primary malignant tumors. 
 
a. Intestinal-type adenocarcinoma (ITAC): 
 Patients have ranged in age from 12 to 86 years. Most series report a 
pronounced male predominance. 
Location: ITACs involve the ethmoid sinus, nasal cavities and maxillary sinus 
in 40%, 27% and 20% cases respectively. In nasal cavities, the inferior and middle 
turbinates are sites of predilection. 
Macroscopy: 
 ITACs present as an irregular, exophytic, pink (or) white mass bulging in 
the nasal cavity or PNS often with a necrotic friable appearance. Some lesions are 
gelatinous. 
Histopathology:  
 Barne divided these tumors into 5 categories - Papillary, colonic, solid, 
mucinous and mixed.The papillary type of well differentiated adenocarcinoma 
which accounts for 18% of cases shows a predominance of papillary architecture 
with occasional tubular glands, minimal cytological atypia and rare mitotic figures. 
The colonic (moderately differentiated) adenocarcinoma representing 40% cases 
shows a predominance of tubulo glandular architecture, rare papillae, increased 
nuclear pleomorphism and mitotic activity. The solid type (20%) shows loss of 
17
  
differentiation characterized by solid and trabecular growth with isolated tubule 
formation, marked increase in number of smaller cuboidal cells with nuclear 
pleomorphism, round vesicular nuclei, prominent nucleoli and increase in mitotic 
figures. 
 ITACs with mucinous type have two patterns. In one, there are solid 
clusters of cells, individual glands with intracellular mucin, signet ring cells, and 
short papillary fronds with or without fibrovascular core. The other pattern shows 
the presence of large well formed glands distended by mucus and extra cellular 
mucin pool separated by thin connective tissue septa creating an alveolar type 
pattern.
22
  
b. Sinonasal non-intestinal type adenocarcinoma: 
 Adenocarcinoma arising in the sinonasal tract which are non-intestinal type 
are divided into low and high grade subtypes. It occurs in adults with slight male 
preponderance.They are encountered in ethmoid sinus and maxillary sinus.  
Macroscopy: The appearance varies including well demarcated to poorly defined 
and invasive flat to exophytic or papillary growths with a tan white to pink colour 
and friable to firm consistency. 
Histopathology: 
 The low grade non-intestinal type adenocarcinomas are circumscribed or 
invasive and have a glandular or papillary growth. Numerous uniform small glands 
or acini are lined by mildly pleomorphic cuboidal to columnar cells arranged in a 
back to back or coalescent pattern with little or no intervening stroma. The high 
grade non-intestinal type adenocarcinomas are invasive tumors with predominately 
18
  
solid growth pattern, but glandular and papillary patterns can also be present. 
Tumors are characterized by moderate to marked cellular pleomorphism, high 
mitotic activity including atypical forms and necrosis. 
Prognosis: The low grade neoplasms have an excellent prognosis while high 
grade neoplasms have a dismal prognosis with a 3 year survival rate of 
approximately 20%.
22
 
 
4. SALIVARY GLAND-TYPE CARCINOMAS 
a. Adenoid cystic carcinoma : 
It is the most frequent malignant salivary gland type tumor of the sinonasal 
tract. The age range is wide ranging from 11 to 92 years. The majority develop in 
the maxillary sinus and nasal cavity. The long term prognosis is poor and 10 year 
survival rate is only 7%.
23 
Microscopically, it is composed of bland epithelial cells with oval nuclei 
and little cytoplasm. The nuclei have coarse chromatin and prominent nucleoli. 
Myoepithelial cells are variably present. It produces three architectural patterns - 
Tubular (low grade), cribriform (intermediate grade) and solid (high grade). They 
are usually composed of a mixture of two or three distinct patterns and tumors are 
graded according to the most aggressive pattern present (30% or more).
24
 
 
b. Mucoepidermoid carcinoma(MEC): 
They are rare at this site and should be distinguished from the more 
aggressive variants of squamous cell carcinoma especially adeno squamous 
carcinoma.
25 
19
  
Microscopically, MECs are composed of varying proportions of epidermoid 
cells, mucus-secreting cells (mucocytes), and intermediate cells, which are cells of 
intermediate differentiation between the other two cell types.
 
 
c. Other tumors: 
 A variety of other salivary gland – type carcinomas have been rarely 
reported in the nasal cavity and paranasal sinuses. These include epithelial-
myoepithelial carcinoma,
26
 malignant myoepithelioma,
27 
carcinoma expleomorphic 
adenoma,
28
 adenocarcinoma
29
 and basal cell adenocarcinoma
30
. 
 
5. SINONASAL NEUROENDOCRINE CARCINOMA (SNEC) 
 SNECs occur at superior nasal cavity, superior turbinates, ethmoids, 
anterior or middle turbinates. It is a cellular tumor lacking fibrillary background. 
Gland formation may be seen, but the Homer – Wright rosettes are not. The tumor 
forms either solid sheets, ribbons, or trabeculae,or zell ballen formation. Necrosis 
and increased mitotic figures may be seen. Goblet cells or signet – ring cells may 
be seen. The main differential diagnosis is olfactory neuroblastoma. Multiple local 
recurrences and locoregional metastasis are seen.
31
 
 
Immunohistochemistry:Immunohistochemical studies in a limited number of 
SNECs suggest that they are almost invariably positive for keratins ,with variable 
expression of neuronspecific enolase, chromogranin, and synaptophysin.
94
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BENIGN EPITHELIAL TUMORS 
1. SINONASAL TYPE (SCHNEIDERIAN) PAPILLOMAS 
7, 33, 34
 
The ectodermally derived lining of the sinonasal tract, termed schneiderian 
membrane, may give rise to sinonasal type papillomas. Three morphological types 
are inverted (transitional), cylindrical (oncocytic or columnar cell) and fungiform 
(exophytic, septal papilloma). 
Inverted papillomas are most common in the fifth to eighth decades. 
Inverted papillomas occur along the lateral nasal wall (middle turbinate or ethmoid 
recesses) with secondary extension into paranasal sinuses. Typically, the 
schneiderian papillomas are unilateral, but bilateral papillomas may occur.  
Inverted papillomas are large, bulky, translucent masses with a red to gray 
colour, varying from firm to friable in consistency. Histologically, these tumors 
have an endophytic or “inverted” growth pattern consisting of markedly thickened 
bland squamous epithelial proliferation growing downward in underlying stroma. 
The epithelium varies in cellularity and is composed of squamous, transitional and 
columnar cells with admixed mucocytes and intraepithelial mucous cysts. A mixed 
chronic inflammatory infiltrate is seen within all layers of the surface epithelium.  
 Complications associated with schneiderian papillomas include recurrence 
(6-33%) and malignant transformation (7-10%).
34
 Inverted papillomas and 
cylindrical cell papillomas can undergo malignant transformation and varies from 
5 to 15% cases. The majority of malignancies associated with inverted papillomas 
are squamous cell carcinomas (keratinizing and nonkeratinizing), varying in 
appearance from well to poorly differentiated.  
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Recently in a study carried out in Japan
32
, it was shown that squamous cell 
carcinoma antigen (SCCAI) was over expressed in sinonasal inverted papilloma 
tissues compared to normal nasal epithelium. It was measured by Westernblot 
analysis and shown as potential useful biological marker in patients with sinonasal 
inverted papilloma. 
 
II. SOFT TISSUE TUMORS 
 
1. MALIGNANT TUMORS 
 
a. Fibrosarcoma
37
: 
These tumors are rare (<3%) of all non-epithelial tumors. Most arise in one 
or more paranasal sinuses, while origination confined to the nasal cavity alone is 
less common. The tumors are circumscribed,unencapsulated and fleshy.Spindle 
cells are arranged in herring bone pattern and in fascicles. 
 
b. Rhabdomyosarcoma (RMS): 
 The embryonal subtype predominates in children while the alveolar subtype 
predominates in adults. The pleomorphic subtype is rare
41
. In adults, RMS is more 
common in the ethmoid sinuses followed by maxillary sinuses and nasopharynx.
42
 
Alveolar RMS has fibrous septa separating clusters of loosely cohesive 
groups of small to medium sized round tumor cells with hyperchromatic nuclei and 
scant eosinophilic cytoplasm. Multinucleated giant cells with overlapping 
peripheral nuclei are often present.Other variants includes botryoid and 
pleomorphic type.
43
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Other sarcomas such as Leiomyosarcoma,
40
 Malignant fibrous 
histiocytoma
38,39
 angiosarcoma
44
  and MPNST
45
 have been reported, but rare in the 
sinonasal tract. 
 
2. BORDERLINE AND LOW MALIGNANT POTENTIAL TUMORS 
 
a. Desmoid-type fibromatosis: 
Sinonasal tract is uncommonly involved. The maxillary sinus and turbinates 
are visually affected.
46
 An infiltrative growth pattern with low to moderate 
cellularity comprising broad fascicles of bland looking spindle cells and collagen 
fibers arranged in uniform direction. Keloid like collagen may be seen
47
. 
b. Inflammatory myofibroblastic tumor:  
Uncommonly occurs in the sinonasal tract
48
. 
c. Glomangiopericytoma (Sinonasal – type hemangiopericytoma): 
 These comprise <0.5% of all neoplasms. Most frequently arise unilaterally 
in the nasal cavity. All ages can be affected (in utero to 86 years) but the peak is in 
the 7
th
 decade
49
.  
These tumors are composed of uniform, ovoid or spindle cells forming tight 
aggregates with little intervening stromal collagen. High grade 
hemangiopericytomas is this region can metastasize, so these should be 
distinguished from low grade forms and angiofibroma
50
.These tumors are indolent 
in their behavior
6
.  
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3. BENIGN TUMORS 
a. Hemangiomas 
51,7 
Although hemangiomas are common lesions of the head and neck (Batsakis 
and Rice, 1901 a, b), those of the nasal cavity and PNS are rare. A review of 
English literature until 1990 revealed only 62 cases of septal hemongiomas and 32 
cases of maxillary sinus hemangioma (Sheppard and Michelson, 1990). However 
hemangiomas of the maxillary sinus need to be considered in the preoperative 
diagnosis since surgery and even biopsy can lead to a sudden loss of large 
quantities of blood (Engel et al., 1990).
58 
Hemangiomas are benign vascular lesions (Batsakis, 1984). Lobular 
capillary hemangioma (LCH) most often found in the anterior portion of the nasal 
septum in an area referred to as Little’s area or Kisselbach’s triangle; the second 
most common sinonasal location is from the turbinates. 
The gross appearance of LCH is a smooth, lobulated, polypoid red mass 
measuring upto 1.5cm in diameter. 
Histologically, LCH is characterized by submucosal vascular proliferation 
arranged in lobules or clusters composed of central capillaries and small ramifying 
tributaries. 
  
b. Schwannoma: 
Less than 4% schwannomas involve the nasal cavity and paranasal sinuses 
and occur in middle aged adults with an equal gender distribution .Most commonly 
involves the ethmoid and maxillary sinuses followed by the nasal cavity, sphenoid 
and frontal sinuses.  
24
  
Gross: 
They measure up to 7 cm, nonencapsulated and are globular firm to 
rubbery, yellow tan masses. Cut surfaces show tan grey, yellowish solid to myxoid 
and cystic tissue, with haemorrhage. 
 
Histopathology: 
Tumor  is composed of cellular Antoni A areas with Verocay bodies and 
hypocellular myxoid Antoni B areas .The cells are fusiform with elongated 
fibrillary cytoplasm and buckled to spindled nuclei with little pleomorphism. 
Small to medium sized vessels with ectasia, thrombosis and perivascular 
hyalinization are seen in the Antoni B area. Extensive degenerating changes can 
occur.  Malignant transformation is exceptional.
52,53
 
 
c) Craniopharyngioma 
Rarely, craniopharyngiomas arise in the the nasal cavity and the sphenoid, 
ethmoid and maxillary sinus. The microscopic appearance is similar to that of 
sellar adamantinomatous craniopharyngiomas with their epithelial lobules, 
peripheral palisading, and internally loose epithelial cells reminiscent of stellate 
reticulum.  
Other benign tumors include leiomyoma, neurofibroma,
54
 meningioma,
55
 
myxoma and salivary gland type of adenomas.
35, 36
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III. TUMORS OF BONE AND CARTILAGE 
 
A. MALIGNANT TUMORS 
 
1. Chondrosarcoma:
56,57
  Chondrosarcomas account for less than 16% of 
all sarcomas of the nasal cavity, paranasal sinuses and nasopharnyx. 
Chondrosarcoma affects older adults with male predilection.  
Histopathology: 
Chondrosarcomas are often lobulated and show round to oval cells in 
lacunae with a blue chondroid matrix with myxoid change. Increased cellularity 
and permeation of the intertrabecular spaces of bone distinguish them from 
chondroma.  
 
 
2. Osteosarcoma: 
 They are extremely rare in nasal cavity and paranasal sinuses. In the 
maxilla, alveolar ridge and antrum are predominantly involved.
58,59
 
 
3. Chordoma: 
 Chordomas sometimes appear as a mass in the nasopharynx or nasal 
cavity.
60
 The cells have vacuolated cytoplasm (physalipherous), situated in myxoid 
stroma. 
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B. BENIGN TUMORS 
 
1. Giant Cell Lesion: (Giant Cell granuloma, giant cell reparative 
granuloma) 
  The lesion consists of spindle, ovoid or round histiocyte like cells set in a 
well vascularised fibrous tissue. The cells are mononuclear, binuclear and 
trinuclear, and they may form giant cells with approximately 10 to 20 nuclei. The 
giant cells may aggregate in groups of 6 to 12 cells.
61
  
 
2. Giant Cell Tumor
62
: 
 The skull, sphenoid, ethmoid and temporal bone are almost exclusively 
involved. Clinical symptoms depend on the site of occurrence. The tumor is 
characterized by abundant multinucleated osteoclast giant cells, with up to 50-100 
nuclei that are evenly distributed among sheets of stromal cells.  
3. Ameloblastoma:
 64, 65, 66
 
 Ameloblastomas are very rare in the sinonasal tract and nasopharyx. These 
are commonly seen in mandible but 15-20% occurs in maxilla. These represent 1% 
of odontogenic lesions. S.P.Tyagi (1993) reported a case of ameloblastoma 
presenting as a nasal polyp in a 60 years old male which recurred twice. 
 
Histopathology: 
 A wide variety of histological patterns have been described (Asisenberg, 
1953). The two main forms are follicular and plexiform variants. The follicular 
variant is the commonest and mimics the enamel organ in the developing tooth. It 
consists of sharply circumscribed epithelial islands with a palisaded border of tall 
27
  
columnar cells (Ameloblasts) which enclose a more loosely arranged cellular 
component, resembling a stellate reticulum. Squamous metaplasia may occur in 
the central areas sometimes proceeding to the formation of epithelial pearls. The 
plexiform type consists of thin branching epithelial cords enclosing numerous 
spaces and presenting a cribriform pattern which may be confused with cribriform 
adenocarcinoma. Some of the cords may be expanded to contain stellate cells; and 
a mixture of plexiform and follicular pattern may occur. The connective tissue 
stroma is of a loose character and often relatively acellular. Other variants include 
acanthomatous, mucoepidemoid, granular cell and hemangiomatous. At times, 
different variants can be seen in the same tumor.Recurrence is fairly common.
 
 
4.Ossifying Fibroma (OF)
67
: Synonyms are cementifying fibroma, cemento 
ossifying fibroma, juvenile (active / aggressive) ossifying fibroma. A description 
of a mandible tumor in a 35 year old female consistent with OF has been reported 
earlier (Menzel, 1972). Oral pathologists have traditionally classified these lesions 
on the basis of whether they are odontogenic or non-odontogenic in origin.Juvenile 
trabecular ossifying fibroma (JTOF) and Juvenile Psammomatoid ossifying 
fibroma (JPOF) are two histologic variants of ossifying fibroma. OF is mostly seen 
in the posterior mandible. JPOF mainly occurs in the bony walls of the paranasal 
sinuses whereas in JTOF, the maxilla is the site of predilection. 
 They most commonly occur in the 2
nd
 to 4
th
 decades with a predilection for 
females. 
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Histopathology:  
 Ossifying fibroma is composed of fibrous tissue that varies in cellularity 
from areas with closely packed cells to sparsely cellular areas within the same 
lesion. The mineralized component may consist of woven bone, lamellar bone and 
acellular to poorly cellular basophilic and smoothly contoured deposits thought to 
be cementum. 
Other rare benign bone and cartilage tumors include osteoid osteoma,
63,7
 
chondroma, chondroblastoma,
68,69 
chondromyxoid fibroma, osteochondroma, 
osteoblastoma and nasal chondro mesenchymal hamartoma.
70
 
 
IV. HAEMATOLYMPHOID TUMORS 
 
1. Non-Hodgkin Lymphoma (NHL): Malignant lymphoma is the 
second most common malignancy of the nasal cavity and paranasal sinuses 
following squamous cell carcinoma. It accounts for 14% of all cancers in these 
sites.
71
 Although many types of NHL can occur in the nasal cavity, the most 
common lymphoma type is extranodal/NK/T-cell lymphoma of nasal type, 
especially in Asian population.
98
 Other peripheral T-cell lymphomas, such as 
anaplastic large cell lymphoma can also occur in the sinonasal region. Lymphoma 
presenting in the paranasal sinuses are frequently B-celllymphomas, with diffuse 
large B-cell lymphoma (DLBCL) is being the most common. Other B-cell 
lymphomas include Burkitt’s lymphoma,follicular lymphoma,extranodal marginal 
zone B-cell lymphoma of MALT type and mantle cell lymphoma.
72
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2. Extramedullary plasmacytoma: Extramedullary plasmacytoma of the 
sinonasal region is histologically similar to plasmacytoma of bone or multiple 
myeloma. Most frequent sites of involvement in the head and neck region are nasal 
cavity, paranasal sinuses and nasopharynx.
73, 74
 
Grossly, the tumors are raised submucosal lesions with fleshy, dark red-
grey surfaces, primarily involving the nasal cavity. 
Other tumors include extramedullary myeloid sarcoma
75
, histiocytic 
sarcoma
76
 and Langerhans cell histiocytosis
77
. 
 
V. NEUROECTODERMAL TUMORS 
 
1. Ewing sarcoma and primitive neuroectodermal tumor (ES/PNET)
 These are interrelated primitive tumors, the majority of which possess 
rearrangements of the EWS gene 22q12 to 11q24. In the head and neck, both may 
rarely occur in osseous and intraosseous location. Sinonasal ES/PNET is rare.  
ES/PNET are histologically similar and composed of uniform, small round 
malignant cells with little cytoplasm.Immunoprofile includes reactivity for CD99 
and vimentin.
6
 
 
2. Olfactory neuroblastoma
78
: 
 Olfactory neuroblastoma is described as uncommon tumor of nasal cavity, 
comprising about 3% all true nasal tumors.
79
 Berger et al (1924) reported the first 
case of olfactory neuroblastoma. It is slow growing but locally aggressive 
malignant tumor of nasal cavity. It is also called olfactory neuroepithelioma and 
olfactory neural neoplasm. It is found predominantly in adolescents and Mendeloff 
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(1957) reported the age range of patient between 8-79 years. The most common 
site of origin is in the upper nasal cavity in the region of the cribriform plate.
80 
Gross appearances: 
 Olfactory neuroblastomas grossly appear Glistening, mucosa covered, soft, 
gray, pink to brown, polypoid mass sometimes friable and hemorrhagic on 
manipulation. The mass varies from 1 cm to a bulky, massive tumor involving the 
entire nasal cavity. Cut section is gritty to cut.
81
 
 
Histopathology: 
 Tumor is composed of relatively uniform cells, slightly larger than 
lymphocytes, with round to oval nuclei, either fine or coarse chromation, 
occasional prominent nucleoli and scanty cytoplasm. Nuclear pleomorphism is 
minimal and few mitoses are seen. The cells are embedded within a fibrillary 
background that corresponds to neuronal processes formed by the most 
differentiated of tumor cells. Homer-Wright rosettes (pseudorosettes) and Flexner-
Wintersteiner rosettes are evidence of true olfactory differentiation. Lamellated 
calcifications may be seen. 
 
Immunohistochemistry: 
Immunohistochemical studies have shown that the cells of ONBs express 
neuron-specific enolase, CD56, synaptophysin and chromogranin. The periphery 
of the cell nests shows S-100 protein–positive spindle or stellate cells 
(sustentacular cells), which may be sparse in poorly differentiated, high-grade 
ONBs. Neurofilament protein and class III beta-tubulin are seen within the 
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cytoplasm and fibrillary matrix.
83
 ONBs are usually negative for CK; however, 
focal immunoreactivity may be found in approximately 20% to 25% of 
tumors,
82,83,84
 generally in areas with epithelial differentiation. 
 
3. Mucosal malignant melanoma: 
 Sinonasal melanomas represent less than 3.6% of sinonasal tumors; less 
than 2.5% of all malignant melanomas occur in the sinonasal tract. They are more 
common in the nasal cavity (especially septum) than in the paranasal sinuses. The 
antrum is involved in 80% of cases, usually together with the nasal cavity. Rare 
cases developed in the ethmoids; the frontal and sphenoid sinuses are virtually 
never primarily affected.
85
 The age range is predominantly 50 to 70 years. Grossly 
sinonasal melanomas vary in colour from white to gray, brown or black. 
Microscopically, they manifest a myriad of patterns composed of varying cell 
types including epithelioid, sarcomatoid, plasmacytoid or clear cell. Tumor cells 
grow in sheets or nests of variable size and are polygonal and many have vesicular 
nuclei and prominent nucleoli. In a few cases, spindle cells predominate, 
mimicking sarcoma. The amount of melanin varies considerably.
86
 The prognosis 
is generally poor because of advanced local disease.
87
 
 
Immunohistochemistry: 
Melanomas are usually positive for vimentin, S-100 (95%), HMB-45 
(98%), and other melanocytic markers (tyrosinase, MART1/A103, microphthalmia 
transcription marker). In amelanotic tumors, the use of these stains may be helpful 
in establishing a definitive diagnosis. 
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VI. GERM CELL TUMORS
88, 89, 90, 91
 
Germ cell tumors of sinonasal tract include immature teratoma, teratoma 
with malignant transformation, yolk sac tumor, teratocarcinoma, mature teratoma 
and dermoid cyst. The incidence of these tumors is exceedingly rare with very few 
reported cases. 
 
VII. SECONDARY TUMORS 
65, 6
 
Metastasis to the nasal cavity and paranasal sinuses are rare and may occur 
in any age group. 50% of secondaries in the region of nose and PNS were derived 
from primary renal cell carcinoma. In order of frequency, metastatic tumors of 
nose and PNS arise from kidney, bronchus, urogenital and gastrointestinal tract. 
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MATERIALS AND METHODS 
 The surgical specimens received in the Institute of Pathology, Madras 
Medical College, Chennai from the Upgraded Institute of Otorhinolaryngology, 
Government General Hospital, Chennai during the period of January 2007 to October 
2011 formed the material for this study. Small biopsy specimens and excision biopsy 
specimens and resection specimens were included. Inadequate or unrepresentative 
biopsy material was excluded from the study. 
 The clinical features such as age and sex of the patient, site of lesion and 
type of surgery done were noted. 
 The tissues were routinely processed and paraffin blocks were made and 
histological sections of 5 to 6 micrometer were taken in Leica microtome and 
routinely stained with hematoxylin and eosin stains. Special stains - periodic acid 
schiff (PAS), reticulin and Masson Fontana were done wherever necessary. 
Microphotographs were taken. Immunostains were done wherever found necessary. 
 
MICROSCOPIC ANALYSIS 
 The microscopic analyses were done from all the available slides. These 
included the histological pattern, cellular features, pleomorphism, mitosis, necrosis, 
vascularity and secondary changes. Diagnosis was made and the tumors were 
classified as benign or malignant. 
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IMMUNOHISTOCHEMISTRY (IHC) 
 Immunohistochemistry (IHC) refers to the process of localizing antigens in 
a tissue section by binding specifically with antibodies. Cases for IHC were selected 
after viewing the H & E sections. Slides were coated with chrome alum, and subjected 
to Antigen Retrival using the Microwave technique with buffer solution. Slides were 
then treated by HRP (Horsh radish peroxidase) polymer technique. 
HRP POLYMER TECHNIQUE 
 The coated slides were taken through the following steps 
1. Treatment with peroxidase block-for incubation of endogenous peroxidase in the 
tissue for 20 minutes, washed in PBS buffer for 5 minutes. 
2. Applications of power block O-to block nonspecific antigen-antibody reactions for 
20 minutes. The excess power block was blot dried. 
3. Applications of primary antibody - murine antibodies for 60 minutes. Washed in 
PBS buffer for 5 minutes. 
4. Applications of super enhancer for 30 minutes which increased the sensitivity of 
antigen – antibody reaction thereby enhancing the final reaction product. 
5. Application of SS label - Secondary antibody from goat with the tagged horse 
radish peroxidase enzyme for 30 minutes. Washed in PBS buffer. 
35
 
 
6. Application of DAB (Diaminobenzidine) Chromogen for 5 minutes-which was 
cleared by the enzyme to give the colored product at antigen sites. Washed in distilled 
water for 5 minutes. 
7. The slides were then counter stained with hematoxylin. Slides were air dried and 
mounted with DPX (Dibutylpthalate Xylene). 
Undifferentiated malignant neoplasms of the sinonasal tract include SNUC, 
SNEC, Olfactory neuroblastoma, Mucosal malignant melanoma, Lymphoma, PNET, 
Rhabdomyosarcoma. Often they are clinically aggressive and share clinical and light 
microscopic features, which make differentiation of one from the other virtually 
impossible without the use of immunohistochemistry. Nevertheless, differentiating 
these tumors has clinical importance because advances in therapeutic intervention may 
increase survival with good quality of life, and in some instances may achieve a cure. 
For undifferentiated malignant neoplasms and small round cell tumors panel of 
immunohistochemical markers were used that include: Cytokeratin, Synaptophysin, 
Neuron specific enolase, CD 99, vimentin, CD 45, Desmin, S100, HMB 45. 
36
  
 
 
 
 
 
 
 
 
 
OBSERVATION AND 
RESULTS 
 
 
 
 
 
OBSERVATION AND RESULTS 
 
All tumors of nasal cavity and paranasal sinuses received at the Institute of 
Pathology Madras Medical College, Chennai from January 2007 to October 2011 
were included in this study. A Total of 200 tumors were reported. Histopathological 
examination revealed that 107 (53.5%) were malignant and 93 (46.5%) were benign 
with an overall incidence of 0.45%. Epithelial tumors (144) predominated with a 72% 
over nonepithelial tumors (56) with a 28%. The ratio of epithelial to nonepithelial 
tumors was 2.57:1. Presentation of the tumors was equal in right and left sides. 
TABLE-1: Distribution of tumors of Nasal cavity, Paranasal sinuses 
according to the incidence, sex ratio, age and site of presentation 
Diagnosis 
No. of 
Cases 
% M:F 
Peak 
Age 
(decade) 
Nasal 
Cavity 
PNS 
No % No % 
Benign Tumors 
Inverted papilloma 40 43.01 1.6:1 5&7 37 45.12 3 27.27 
Hemangioma 27 29.03 2:1 2&4 26 31.70 1 9.09 
Hemangiopericytoma 7 7.53 2.5:1 5 5 6.09 2 18.18 
Schwannoma 6 6.45 1:1 4 5 6.09 1 9.09 
Ossifying Fibroma 5 5.38 1.5:1 3&4 3 3.65 2 18.18 
Exophytic  Papilloma 3 3.23 M only 3 3 3.65  0 
Ameloblastoma 2 2.15 M only 4&5 1 1.21 1 9.09 
Craniopharyngioma 1 1.08 M only 2 1 1.21  0 
Oncocytic Papilloma 1 1.08 M only 3 1 1.21  0 
Osteoid Osteoma 1 1.08 M only 2  0 1 9.09 
Total 93    82  11  
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 Diagnosis 
No. of 
Cases 
% M:F 
Peak 
Age 
(decade) 
Nasal 
Cavity 
PNS 
No % No % 
Malignant Tumours 
Squamous cell carcinoma 60 56.07 2.7:1 7 30 51.72 30 61.22 
SNUC 10 9.35 4:1 5 7 12.06 3 6.12 
Adenoidcystic Carcinoma 8 7.48 1.6:1 7 5 8.62 3 6.12 
SNEC 6 5.61 1.5:1 3&5 5 8.62 1 2.04 
Adenocarcinoma 5 4.67 
M 
only 
7 3 5.17 2 4.08 
Mucoepidermoid 
Carcinoma 
5 4.67 1:1.5 5 1 1.72 4 8.16 
Ameloblastic Carcinoma 2 1.87 
M 
only 
5&7  0 2 4.08 
Melanoma 2 1.87 
M 
only 
4&6 2 3.44  0 
Olfactory Neuroblastoma 2 1.87 1:1 2&5 1 1.72 1 2.04 
Plasmacytoma 2 1.87 1:1 5&7 2 3.44  0 
PNET 2 1.87 
M 
only 
2 1 1.72 1 2.04 
Hemangioendotheloima 1 0.93 
M 
only 
7 1 1.72  0 
Fibrosarcoma 1 0.93 
M 
only 
4  0 1 2.04 
Metastasis 1 0.93 
F 
only 
5  0 1 2.04 
Total 107    58  49  
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NEOPLASTIC LESIONS - BENIGN 
Out of 200 samples, 93 tumors were benign with an incidence of 46.5%. It was 
noted that most patients with benign tumors were in the 5
th
 decade with a mean age of 
42.5 years. The male to female ratio was 1.7:1 for benign tumors. Epithelial tumors 
(47) constitute 50.5% and nonepithelial tumors (46) constitute 49.5% with a ratio of 
1.02:1.  The age of presentation of individual tumors are variable and the peak age of 
presentation was 5
th
 decade followed by 3
rd
 decade (Table 2). 
TABLE-2: AGE DISTRIBUTION OF BENIGN NEOPLASMS 
Age group (years) Number Percentage 
<10 1 1.07 
10 to 20 11 11.83 
21 to30 17 18.28 
31 to 40 14 15.05 
41 to 50 21 22.58 
51 to 60 11 11.83 
61 to 70 14 15.05 
71 to 80 3 3.23 
81 to 90 1 1.07 
 Total 93 100 
 
GRAPH 1: AGE DISTRIBUTION-BENIGN NEOPLASMS 
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Males predominated over females with a ratio of 3:1(Table-3). 
 
TABLE-3: SEX DISTRIBUTION OF BENIGN NEOPLASMS 
Sex Number Percentage 
Male 59 63.44 
Female 34 36.56 
Total 93 100 
 
 
GRAPH 2: SEX DISTRIBUTION-BENIGN NEOPLASMS 
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The benign tumors of nasal cavity and paranasal sinuses occurred with variable 
frequency. Amongst the 93 benign tumors 82 (88.18%) were from the nasal cavity and 
11 (11.82%) were from the paranasal sinuses. Maxillary sinus was the commonest site 
in the paranasal sinuses (Table-4).   
TABLE-4: SITE OF BENIGN NEOPLASMS 
  
 
GRAPH 3: SITE OF LESION-BENIGN NEOPLASMS 
 
 
Of 93 benign tumors the most common was inverted papilloma which 
constituted 43.01% (40); followed by haemangioma 29.03% (27).The other tumors 
were craniopharyngioma, osteoid osteoma, ameloblastoma, ossifying fibroma,  
Site Number Percentage 
Nasal cavity 82 88.18 
Maxillary sinus 7 7.53 
Ethmoid sinus 2 2.15 
Frontal sinus 1 1.07 
Sphenoid sinus 1 1.07 
Total 93 100 
41
hemangiopericytoma, exophytic papilloma, oncocytic papilloma and schwannoma 
(Table-5). 
TABLE-5: HISTOLOGICAL DIAGNOSIS OF BENIGN NEOPLASMS 
Types Frequency Percentage 
Ameloblastoma 2 2.15% 
Hemangioma 27 29.03% 
Craniopharyngioma 1 1.08% 
Inverted papilloma  40 43.01% 
Exophytic  Papilloma 3 3.23% 
Oncocytic Papilloma  1 1.08% 
Ossifying Fibroma  5 5.38% 
Osteoid Osteoma  1 1.08% 
Schwannoma 6 6.45% 
Hemangiopericytoma  7 7.53% 
Total  93 100.00% 
 
GRAPH 4: HISTOLGICAL DIAGNOSIS OF BENIGN NEOPLASMS 
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NEOPLASTIC LESIONS - MALIGNANT 
 
Out of 200 samples 107 tumors was malignant constituting 53.5% showing a 
slight predominance over benign tumors. Malignant tumors occurred in patients one 
decade later than benign tumors with a mean age of 52.05 years and the male to 
female ratio was 2.3:1. Among malignant tumors, epithelial tumors (97) constituting 
90.65% predominated over non epithelial tumors (10) constituting 9.35% with a ratio 
of 9.7:1. The age range varied from second to ninth decade of life but the peak age of 
presentation was 5
th
 decade followed by 7
th
 decade (Table-6). 
TABLE-6: AGE DISTRIBUTION OF MALIGNANT NEOPLASMS 
 
 
GRAPH 5: AGE DISTRIBUTION OF MALIGNANT NEOPLASMS 
 
 
 
 
 
Age group(years) Number Percentage 
<10 0               0 
10 to 20 4 3.74 
21 to30 4 3.74 
31 to 40 15 14.02 
41 to 50 28 26.17 
51 to 60 22 20.56 
61 to 70 27 25.23 
71 to 80 6 5.61 
81 to 90 1 0.93 
Total 107 100 
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 Males showed a higher incidence than females with a male to female ratio of 
2.3:1 (Table-7). 
 
TABLE-7: SEX DISTRIBUTION OF MALIGNANT NEOPLASMS 
 
 
GRAPH 6: SEX DISTRIBUTION OF MALIGNANT NEOPLASMS 
 
Sex Number Percentage 
Male 75 70.09 
Female 32 29.91 
Total 107 100 
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Out of the 107 malignant tumors 58 were from the nasal cavity (54.21%) and 
49 were from paranasal sinuses (45.79%). Amongst paranasal sinuses maxillary sinus 
was the commonest site (Table-8). 
TABLE-8: SITE OF MALIGNANT NEOPLASMS 
Site Number Percentage 
Nasal cavity 58 54.21 
Maxillary sinus 38 35.51 
Ethmoid sinus 4 3.74 
Frontal sinus 2 1.87 
Sphenoid sinus 5 4.67 
Total 107 100 
 
GRAPH 7: SITE OF MALIGNANT NEOPLASMS 
 
 
The most common malignant tumor encountered was squamous cell 
carcinoma 60 cases (56.07%), followed by Sinonasal undifferentiated carcinoma 
(SNUC) 10 cases (9.35%). The other malignant lesions that involved the region were 
adenoid cystic carcinoma, adenocarcinoma, mucoepidermoid carcinoma, sinonasal 
neuroendocrine carcinoma. olfactory neuroblastoma and ameloblastic carcinoma. Rare 
45
tumors included mucosal malignant melanoma, plasmacytoma, PNET, fibrosarcoma 
and clear cell metastatic deposits. (Table-9) 
TABLE-9: HISTOLOGICAL DIAGNOSIS OF MALIGNANT 
NEOPLASMS 
Types Frequency Percentage 
Adenocarcinoma 5 4.67% 
Adenoid cystic carcinoma 8 7.48% 
Ameloblastic carcinoma 2 1.87% 
Hemangioendothelioma 1 0.93% 
Melanoma 2 1.87% 
Mucoepidermoid carcinoma 5 4.67% 
Olfactory Neuroblastoma 2 1.87% 
Fibrosarcoma 1 0.93% 
Plasmacytoma 2 1.87% 
SNUC 10 9.35% 
SNEC 6 5.61% 
PNET 2 1.87% 
Squamous cell carcinoma  60 56.07% 
Metastasis  1 0.93% 
Total 107 100.00% 
  
GRAPH 8: HISTOLOGICAL DIAGNOSIS OF MALIGNANT 
NEOPLASMS 
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The most common clinical presentation was mass in the nose which constituted 
180 cases (90%)  (Table-10).  
TABLE-10: CLINICAL PRESENTATION 
Clinical presentation Frequency Percentage 
Mass in the nose 170 85 
Bleeding  polyp 6 3 
Polyp 10 5 
Mass &epistaxis 8 4 
Epistaxis&nasal obstruction 2 1 
Mass&proptosis 2 1 
Mass&headache&blurr.vision 1 0.5 
Nasal obstruction 1 0.5 
 
GRAPH 9: CLINICAL PRESENTATION 
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A panel of immunohistochemical markers that included cytokeratin, NSE, 
synaptophysin, vimentin, desmin, S100, CD99 and CD45 was employed for 15 cases 
of undifferentiated carcinoma. 10 cases showed diffuse,moderate staining for 
cytokeratin and no reactivity for other markers except for 2 which in addition to 
cytokeratin showed focal reactivity for NSE. All the 10 were finally diagnosed as 
Sinonasal undifferentiated carcinoma (SNUC). 5 showed diffuse moderate staining for 
cytokeratin, NSE, synaptophysin, and were finally categorized as Sinonasal 
neuroendocrine carcinoma (SNEC). SNUC was the predominant variant (66.67%) 
followed by SNEC (33.33%)  (Table-11). 
TABLE-11: UNDIFFERENTIATED CARCINOMA 
 
 
GRAPH 10: UNDIFFERENTIATED CARCINOMA 
 
 
 
 
 
Undifferentiated 
carcinoma NO Percentage 
SNUC 
10 66.67 
SNEC 
5  33.33 
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An immunohistochemistry panel was employed for 5 small round cell tumors 
(SRCT). Among them we observed that 2 showed reactivity for NSE, synaptophysin, 
S100 and was finally diagnosed as esthesioneuroblastoma(ENB) 40%. Among the 
other 3 PNET was diagnosed in two cases as they showed reactivity for CD 99 and 
vimentin.One was diagnosed as SNEC and showed reactivity for cytokeratin, NSE 
and synaptophysin (Table-12). 
TABLE-12: SMALL ROUND CELL TUMORS 
SRCT          No 
Esthesioneuroblastoma 2 
PNET 2 
SNEC 1 
Total 5 
 
GRAPH 11: SMALL ROUND CELL TUMORS 
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INVERTED PAPILLOMA 
 
Fig.1: An endophytic growth of thickened squamous epithelium 
(H&E100x) 
 
INVERTED PAPILLOMA WITH MALIGNANT TRANSFORMATION 
 
Fig.2: Benign endophytic growth of stratified squamous epithelium with 
adjacent malignant squamous cell carcinoma (H&E100x) 
LOBULAR CAPILLARY HEMANGIOMA 
 
Fig.3: submucosal lobular proliferation of variable sized vascular spaces 
(H&E100x) 
 
HEMANGIOPERICYTOMA
 
Fig.4: Diffuse growth pattern of closely packed spindle cells and vascular 
channels of varying sizes (H&E100x) 
SCHWANNOMA 
 
Fig.5: Cellular Antoni A areas arranged in palisades admixed with loose 
myxoid areas Antoni B areas (H&E100x) 
 
PSAMMOMATOID OSSIFYING FIBROMA 
 
Fig.6: calcified spherules with fibrous stroma(H&E100x) 
 
AMELOBLASTOMA 
 
Fig.7: Neoplasm in follicular pattern lined by columnar epithelium showing 
peripheral palisading with inner stellate reticulam(H&E100x) 
 
CRANIOPHARYNGIOMA 
 
Fig.8: Basaloid appearing columnar cells with peripheral palisading,wet 
keratin and calcification(H&E400x) 
BASALOID SQUAMOUS CELL CARCINOMA 
 
Fig.9: Lobules and nests of basaloid cells with comedo necrosis (H&E100x) 
 
ACANTHOLYTIC SQUAMOUS CELL CARCINOMA 
 
 Fig.10: Pseudoglandular pattern of tumour with acantholysis(H&E100x) 
 
ADENOID CYSTIC CARCINOMA 
 
Fig.11: Cribriform configuration of neoplasm composed of basaloid cells 
with eosinophilic basement membrane material in the lumen (H&E400x) 
 
PAPILLARY ADENOCARCINOMA
 
FIG.12: Papillary configuration of tumour lined by malignant columnar 
epithelial cells with nuclear stratification (H&E100x) 
MUCOEPIDERMOID CARCINOMA 
 
Fig.13: Islands of malignant squamous epithelial cells admixed with mucus 
secreting cells and necrosis (H&E100x) 
 
PLASMACYTOMA
 
Fig.14: Diffuse sheets of plasma cells with eccentrically placed round 
nucleus (H&E100X) 
FIBROSARCOMA 
 
FIG.15: Fascicles and herringbone pattern of spindle shaped cells with 
mild cellular pleomorphism(H&E100X) 
 
FIBROSARCOMA 
 
FIG.16: Neoplastic spindle cells showing positivity for vimentin(IHC100X) 
METASTATIC CLEAR CELL CARCINOMA
 
Fig.17: Neoplasm in solid tubuloalveolar pattern composed of clear cells 
with round nuclei (H&E400X) 
 
MALIGNANT MELANOMA 
 
 
 
 
 
 
 
 
 
 
Fig.18: Neoplasm showing spindle cells and epithelioid cells with 
pleomorphic nuclei (H&E400X) 
 
MALIGNANT MELANOMA 
 
Fig.19: Black pigment (melanin) in the cytoplasm of neoplastic cells     
(Masson Fontana stain 400x) 
 
MALIGNANT MELANOMA 
 
Fig.20: Neoplastic cells showing positivity for HMB 45 (IHC400x) 
OLFACTORY NEUROBLASTOMA
 
Fig.21: CT paranasal sinuses showing tumor in the left nasal cavity and 
ethmoid sinus with intracranial extension 
  
OLFACTORY NEUROBLASTOMA 
 
Fig.22: Neoplasm arranged in nests and lobules in a fibrillary background 
(H&E100X) 
OLFACTORY NEUROBLASTOMA 
 
Fig.23: Neoplasm composed of small round cells with Homer-Wright 
rosettes (H&E400X) 
 
OLFACTORY NEUROBLASTOMA
 
Fig.24: Neoplastic cells showing positivity for neuron specific enolase (NSE) 
(IHC 400X) 
OLFACTORY NEUROBLASTOMA 
 
Fig.25: Aspirate from cervical lymph node shows small round cells with 
occasional rosette formation (FNAC 400X) 
 
PNET 
 
Fig.26: Neoplasm arranged in diffuse dense cellular sheets (H&E100x) 
 
PNET 
 
Fig.27: Uniform small to medium sized round cells with scant cytoplasm 
and rosette formation (H&E400x) 
 
PNET 
 
Fig.28: Neoplastic cells showing membranous positivity for CD99 
(IHC400X) 
PNET 
 
Fig.29: Neoplastic cells showing negativity for cytokeratin (IHC100X) 
 
SINONASAL UNDIFFERENTIATED CARCINOMA 
 
Fig.30: Neoplasm arranged in nests, thick trabeculae with necrosis 
(H&E100X) 
 
SINONASAL UNDIFFERENTIATED CARCINOMA 
 
Fig.31: Neoplastic cells have vesicular nuclei and prominent nucleoli 
(H&E400x) 
 
SINONASAL UNDIFFERENTIATED CARCINOMA 
 
Fig.32: Tumor cells showing positivity for cytokeratin (H&E400x) 
 
SINONASAL NEUROENDOCRINE CARCINOMA 
 
Fig.33: Cellular neoplasm in solid sheets with focal rosette formation 
lacking        neurofibrillary background (H&E 100X) 
 
SINONASAL NEUROENDOCRINE CARCINOMA
 
Fig.34: Larger cells with moderate cytoplasm,Inconspicuous nucleoli       
(H&E 400X) 
SINONASAL NEUROENDOCRINE CARCINOMA
 
Fig.35: Neoplastic cells showing diffuse positivity for NSE (IHC 400X) 
 
SINONASAL NEUROENDOCRINE CARCINOMA 
 
Fig.36: Neoplastic cells showing diffuse positivity for cytokeratin 
(H&E 400x) 
 
  
 
 
 
SQUAMOUS CELL CARCINOMA 
 
Fig.37: Maxillectomy specimen with an irregular infiltrating grey white 
growth 
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DISCUSSION  
The present clinicopathological study of sinonasal tumors includes 200 tumors 
of nasal cavity and paranasal sinuses from January 2007 to October 2011.During the 
above period 44730 specimens were received at the general surgical pathology 
laboratory with an incidence of 0.45%. The rare nature of the tumors is almost a 
universal finding (Okafor, 1983; Harison, 1971; Lilly-Tariah da, 1999).
99 
Of the 200 
cases, 107 were malignant, 93 were benign. Malignant tumors predominated with an 
incidence of 53.5% over benign tumors  with an incidence of 46.5%.The ratio of 
malignant to benign tumors was 1.15:1.144 epithelial tumors(72%) predominated over 
56 nonepithelial tumors (28%). The ratio of epithelial to nonepithelial tumors was 
2.57:1. Male to female ratio was 2.03:1 similar to other studies (Lilly-Tariah da, 1999; 
Mundy et al., 1985;).
99
Age range was 2 to 85 years with an average of 47.6 years.The 
maximum number of cases were present in nasal cavity (70%) followed by paranasal 
sinuses (30%).Among the paranasal sinuses maxillary sinus(75%) was the commonest 
site of presentation. Mass in the nose (85%) was the most common clinical 
presentation. Both sides (Right & Left) involved with equal frequency (50%).  
While reviewing literature of tumors of nasal cavity and paranasal sinuses, it 
was found that various authors have studied these tumors in different aspects, such as 
epithelial tumors, non epithelial tumors and malignant neoplasms. Some have studied 
specific tumor entities like fibro osseus tumors and minor salivary gland tumors. 
Some others have included tumors of nasopharynx while studying tumors of nasal 
cavity and paranasal sinuses. All this lead to some difficulty in finding out the exact 
incidence of various tumors in these studies and comparing with the present study.  
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On analysing the 93 benign tumors it was noted that the commonest in 
incidence was sino-nasal type (schneiderian papillomas).Several authors have reported 
the relative incidence of papillomas (Table-13). 
TABLE-13: COMPARISON OF INCIDENCE OF SINONASAL PAPILLOMAS 
Authors Incidence 
Ghosh and Bhattacharya (1966)
100
 13.46% 
Tondon et al (1971)
101 
23.53% 
Butchanan& Slavin (1972)
102
 20.00% 
Sagar et al (1976)
103
 1.00% 
Bjerregaard et al (1992)
104
 16.67% 
Panchal et al (2005)
96
 34.80% 
Present study (2011) 47.32% 
 
40 cases of inverted papillomas constituted the most common morphologic 
type with an incidence of 43.01% and the predominant age group was seen in 7
th
 
followed by 5
th
 decade. There were 25 males and 15 females forming a ratio of 
1.6:1.One was a recurrent tumor involving the nasal cavity in a male. Osborn 
(1971),Butchanan& Slavain (1972),
102
 Christenson and Smith (1986),
105
 Judd & Zaki 
50(1991)
106 
and Bielamowicz et al (1993)
107
 observed a male preponderance.  
37 inverted papillomas involved the nasal cavity and 3 involved the paranasal 
sinuses.Nasal cavity was observed as the commonest site of involvement by Hyames 
et al(1971)
108
, Lasser et al(1976)
109
, Mujumdar & Beck (1984)
110
 and Panchal et al 
(2005).
96
 However Butchanan & Slavin (1972)
102
, Robin et al (1979), Barnes & Bedett 
51
et al (1984),
111 
Judd & Zaki (1991)
106
 observed paranasal sinuses as the common site 
of involvement by papilloma. 
The commonest histological type encountered was inverted papilloma. 
Microscopy showed an endophytic growth of thickened squamous epithelium 
composed of squamous, transitional, and columnar cells with admixed mucocytes and 
inflammatory cell infiltrate (Fig.1). 9 inverted papillomas showed malignant 
transformation. The histological features revealed predominantly a carcinoma with a 
small proportion of residual papilloma which occurred synchronously (Fig.2).The 
tumors were well to moderately differentiated squamous cell carcinoma with an 
incidence of 18.37% of which 3 were recurrent tumors and remaining 6 showed both 
benign inverted papilloma and malignant component. Lesperance et al (1995) had 
reported 27% malignant transformation in inverted papilloma. Panchal et al (2005)
96
 
reported inverted papilloma with squamous cell carcinoma in 8.16%. 
 One oncocytic  papilloma presented  in the left nasal cavity in a 25 year old 
male and 3  exophytic squamous papillomas presented in the nasal cavity.All the 3 
tumors were seen in males and presented in the 3
rd
 &6
th
 decade. 
Second in order of frequency included hemangiomas with an incidence of 
29.03%. The peak age incidence was equally found in 2
nd
and 4
th 
decade in comparison 
with studies of Sayed et al (1997) who found a peak age incidence in 3
rd
 and 4
th 
decade. The  most common location of hemangioma was nasal cavity.Capillary 
hemangioma was the predominant variant as also noted by Fu & Perzin et al(1974).
112 
Microscopy showed lobular proliferation of variably sized vascular spaces composed 
52
of central capillaries and smaller ramifying tributaries (Fig.3). Males predominated 
over females. There were 3 cases of cavernous hemangioma of which one presented in 
a 2 year old child in the right nasal cavity. 
7 cases of hemangiopericytoma were encountered with an incidence of 7.53%. 
The mean age of presentation was 45 years. There were 5 females and 2 males 
forming a ratio of 2.5:1. Among the 7, five presented in the nasal cavity and two in the 
maxilla. Microscopy showed an unencapsulated cellular neoplasm in diffuse growth 
pattern, in short fascicles of closely packed spindle cells with blunt nuclei, coarse 
chromatin, eosinophilic cytoplasm and vascular channels ranging from capillary size 
to staghorn vasculature (Fig.4). Immunostaining revealed tumor cells which showed 
diffuse positivity for Vimentin and negative for CD 34.There were no recurrent 
tumors. 
Intranasal schwannomas are very rare and less than 100 cases have been 
described in the literature (Buob D et al.2003).
123
 The present study included six cases 
of schwannoma with an incidence of 6.45%.This was slightly higher than the 
incidence of 4% reported by various authors(Hasewaga SL et al .1997).
126
 
All the 6 cases presented in the age range of 30-67 years with a mean age of 
41.7 years and an equal sex ratio. None of the tumors were encapsulated as described 
by Hasewaga SL et al.(1997)
126
 which is a distinctive feature of schwannoma in the 
sinonasal region. Microscopically tumors were composed of cellular areas (Antoni 
type A) with spindle cells arranged in palisades (Verocay bodies), together with more 
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loosely structured areas with myxoid stroma(Fig.5). 5 cases presented in the nasal 
cavity and one in the maxilla. 
5 cases of ossifying fibroma were reported with an incidence of 5.38% and 
male to female ratio of 1.5:1 in the age group of 13 to 32 years. The predominant site 
was the nasal cavity. Four tumors were psammomatous ossifying fibroma and 
microscopy showed fibro-osseous proliferation composed of calcified spherules 
admixed with fibrous stroma (Fig.6).  
Primary ameloblastoma of the sinonasal tract (extragnathic ameloblastoms) is 
unusual and extraordinarily uncommon (Schafer et al .1998).
64
 2 rare cases of 
ameloblastoma were reported with an incidence of 2.15%.The mean age of 
presentation was 39 years. Both cases were male with one presenting in the nasal 
cavity and the other in the maxillary sinus. Microscopy showed follicular pattern 
composed of epithelial islands bounded at the periphery by a layer of columnar cells 
exhibiting hyperchromatic, palisaded and reverse polarized nuclei with inner stellate 
reticulum (Fig.7).   
Osteoma  was reported in one case with an incidence of 1.08% in an 18 year 
old male.This was similar to studies by Eggston et al and others.The tumor involved 
the frontal sinus.The paranasal sinus was the commonest site in studies by 
Sooknundan et al(1986)
63
&others.  
One case of craniopharyngioma was reported in an 18 year old male who 
presented as right nasal cavity mass attached to septum in contrast to Bryne MN et al 
(1999)
129 
who found that the peak age incidence was 1
st
 decade. The tumor was 
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composed of centrally situated stellate cells with small nuclei and clear cytoplasm 
surrounded by a palisade of basaloid appearing columnar cells with polarized nuclei 
(Fig.8).  
Among the 107 malignant tumors it was found that the majority were 
squamous cell carcinomas. Studies on the incidence of squamous cell carcinoma by 
various authors also reveal similar findings. Ghosh et al (1966)
100
noted the incidence 
of 72.70%. The incidence of squamous cell carcinoma in the present study was 
56.07%.Several authors have analysed the age incidence of squamous cell carcinoma 
and the average peak was noted between 50-70 yrs of age (Table-14). 
TABLE-14: COMPARISON OF AGE INCIDENCE OF SQUAMOUS 
CELL CARCINOMA 
Authors  Age in years  
  1 to 10 11 to 20 21 to 30 31 to 40 41 to 50 51 to 60 61 to 70 > 70 
Ghosh and Bhattacharya 
(1966)100     18.80% 54.50% 18.18% 9.09% 
Ascheson et al (1970)115  4.50%   13.64% 22.73% 45.45% 13.64% 
Butchanan& Slavin  
(1972)102     14.20% 14.20% 28.50% 42.80% 
Sagar et al (1976) 1.60% 3.30% 1.60% 6.67% 60.60% 8.33% 8.33% 3.33% 
Bosch et al (1976)113    5% 7.50% 12.50% 32.50% 42.50% 
Das Gupta (1976)114   5.60% 29.50% 28.17% 23.01% 12.60%  
Present study    1.66% 10.00% 18.34% 35.00% 23.33% 11.67% 
 
The present study revealed that the predominant age range was 51 to 60 
years.Males predominated over females in studies by several authors. The present 
study also revealed a male preponderance with a ratio of 2.69:1.The nasal cavity was a 
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slightly preponderant site of involvement over paranasal sinuses. Among the paranasal 
sinuses the maxillary sinus was the predominant site of occurrence. Sagar et al 
(1976)
116
 and other authors have noted a predilection for paranasal sinus over nasal 
cavity. 
Das Gupta (1976),
114
 Gupta et al (1986)
117
 and Panchal et al (2005)
96
 observed 
that moderately differentiated squamous cell carcinoma was most commonly 
encountered. It was also observed that moderately differentiated  squamous cell 
carcinoma predominated  in this  study similar to other authors.10 cases of poorly 
differentiated squamous cell carcinoma were included and all the cases showed 
immunoreactivity for cytokeratin. Uncommon and high grade variants of squamous 
cell carcinoma including two basaloid variant and one each of acantholytic, 
adenosquamous,spindle cell variants were reported. Microscopy of basaloid variant 
showed lobular arrangement of basaloid cells with areas of comedo necrosis admixed 
with focal areas of squamous differentiation (Fig.9).The acantholytic variant showed  
the neoplasm in pseudoglandular pattern (Fig.10).Spindle cell squamous carcinoma 
was confirmed by showing  positive immunoreactivity for cytokeratin and negativity 
for mesenchymal markers.The present study did not include any metastatic squamous 
cell carcinoma. One recurrent tumor involved the maxilla of a 46 year old male. 
  10 cases of sinonasal undifferentiated carcinomas were included with an 
incidence of 9.35%.Studies by other authors revealed the incidence of sinonasal 
undifferentiated carcinoma had a varied range of incidence from 1.7 to 17%.The peak 
incidence was  the 5
th
 decade and males dominated over females in the present study. 
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In a study done in Taiwan by Jeng YM and Sung MT, 36 cases of sinonasal 
undifferentiated carcinoma was reviewed .They found that median age of presentation 
was 53 years with a male female ratio of 2:1. The most common locations were nasal 
cavity and ethmoidal sinus. The commonest site in the present study was the nasal 
cavity. Histopathology showed either small or large tumor cells and was 
predominantly arranged in nests, ribbons, thick trabeculae or sheet like pattern and 
had coarse chromatin, prominent nucleoli and necrosis (Fig.30, Fig.31). 
  8 cases of adenoid cystic carcinoma were reported with an incidence of 7.48% 
and slight preponderance in females,in the age range of 40 to 70 yrs with the peak in 
7
th
 decade similar to other studies. Five cases involved the nasal cavity and three cases 
involved the maxilla. Histopathology showed basaloid cells with scant cytoplasm and 
round to oval hyperchromatic nuclei arranged in tubular and cribriform pattern 
(Fig.11). Four were categorized as grade II and four as grade I..   
Adenocarcinoma of the sinonasal tract was observed in 5 out of 107 malignant 
tumors with an incidence of 4.67%.Several authors have analysed the incidence of 
adenocarcinoma and found it was widely variable ranging from 4%[Lopez et 
al(1990)]
118
 to 42.86%[Tandon and Bahadur et al(1992)].
120
The mean age of 
presentation was 57.6 years. All the five tumors affected males similar to studies by 
Lopez et al (1990).
118
The nasal cavity was the predominant site. Barbeiri et al 
(2003)
119 
noted a preponderance of paranasal sinus involvement,while Tandon et al 
(1992)
120
 noted an increased incidence in the nasal cavity. 
Lopez et al (1990)
118
 observed tubulopapillary variant of intestinal type 
adenocarcinoma as the most common variant (83.33%). Urso et al (1993)
121
 observed 
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that moderately differentiated intestinal type adenocarcinoma was the most common 
histologic type (27.78%). Abecasis et al (2004)
122
observed that 10 out of 14 cases 
were high grade intestinal type adenocarcinoma and 2 out 14 cases were low grade 
Intestinal type adenocarcinoma. The papillary variant of adenocarcinoma 
predominated in the present study. Two tumors were moderately differentiated and 2 
tumors were well differentiated. Microscopy showed a papillary architecture lined by 
malignant epithelial cells with nuclear stratification and mild atypia(Fig.12). One was 
a recurrent tumor which involved the nasal cavities of a male in the 5th decade.The 
present study did not include any metastatic adenocarcinoma. 
  5 cases of mucoepidermoid carcinoma were reported with an incidence of 
4.67%.The peak incidence was in 5
th
 decade with a male to female ratio of 1.5:1. 
Paranasal sinus was the commonest site.Histopathology revealed islands of malignant 
squamous cells admixed with mucus secreting cells (Fig.13).Four were high grade 
tumors and one case was low grade. 
2 cases of plasmacytoma were reported with a incidence of 1.87%.Both 
presented in the nasal cavity with an equal sex incidence and occurred in 5&7
th
 decade 
respectively similar to Roberta De Paula Araujo et al(2008)
130
 except that they found 
male preponderance in their study. Histopathology showed plasma cells in diffuse 
sheets with varying degrees of maturation, round eccentrically placed nucleus with 
paranuclear clear zone and clock face chromatin (Fig.14).There was no evidence of 
multiple myeloma elsewhere.  
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Two cases of ameloblastic carcinoma were included which presented in the 
maxilla of two males in the 5
th
 decade and 7
th
 decade respectively with an incidence of 
1.87%. 
One rare case of spindle cell sarcoma involved the maxilla of a 38 year old 
male with an incidence of 0.93%.Histopathology showed spindle shaped cells in 
fascicles and herring bone pattern with mild cellular pleomorphism provisionally 
diagnosed as fibrosarcoma - low grade (Fig.15).This was supported by 
immunohistochemistry by vimentin reactivity (Fig.16) and cytokeratin negativity 
similar to G.plaza et al. (2006).
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  One case of hemangioendothelioma was encountered which presented in the 
nasal cavity of a 65 year old male with an incidence of 0.93%.Histopathology showed 
rounded epithelioid tumor cells with intracytoplasmic lumina arranged in nests and 
strands with angiocentric growth pattern similar to study by Chih –Chieh Tseng et al 
(2005).
124
 
One case of metastatic clear cell carcinomatous deposits was included 
involving the sphenoid sinus of a 45 year old female with an incidence of 0.93%. 
Histopathology showed solid tubuloalveolar pattern of clear cells with round nuclei 
(Fig.17). PAS stain showed positivity in the cytoplasm of tumor cells. 
Two cases of malignant melanoma were reported with an incidence of 1.87% 
similar to other studies (Shaw et al.1977, Snow et al 1978).
127, 128 
Both presented in the 
nasal cavities of males aged 40 and 54 years respectively similar to Zafer et al 
(2008).
95 
Histopathology showed features similar to other undifferentiated neoplasms 
of sinonasal tract showing malignant epithelioid and spindle cells with pleomorphic 
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nuclei and eosinophilic nucleoli with evidence of melanin deposition (Fig.18). Masson 
Fontana stain showed positivity in the cytoplasm of tumor cells (Fig.19). 
Immunostaining revealed tumor cells which were positive for markers HMB45, S100 
confirming the diagnosis of melanoma (Fig.20). 
The present study included 5 small round cell tumors (SRCT) and 15 
undifferentiated carcinomas. For confirmation and further subcategorization a panel of 
immunohistochemical markers that include cytokeratin, NSE, synaptophysin, CD99, 
vimentin, CD45, desmin, S100 and HMB 45 were employed. Among the Five cases of 
SRCT,two showed positivity for NSE, synaptophysin, and S100 confirming the 
diagnosis of olfactory neuroblastoma (Fig.24). Two showed positivity for CD99 and 
vimentin and were negative for other markers thus confiming PNET (Fig.28, Fig.29). 
One tumor showed positivity for cytokeratin, NSE, synaptophysin and a final 
diagnosis of SNEC was made. 
The incidence of olfactory neuroblastoma in the present study was 1.87%. Of 
the two olfactory neuroblastomas,one presented in a 20 year old female involving the 
ethmoid sinus and the other in a 48 year old male involving the nasal cavity.A 
bimodal peak in age was observed similar to Maran et al.1993.
131 
The tumor was 
disposed in lobules and nests and composed of small round cells with high N/C ratio, 
small uniform hyperchromatic nuclei with salt and pepper type of chromatin, Homer-
Wright rosettes in a fibrillary background with a Hyams grade I (Fig.22, Fig.23). One 
showed intracranial extension and cervical lymph node metastasis with a Kadish stage 
C. FNAC of cervical node revealed small round cells with occasional rosette 
formation confirming metastasis to cervical node (Fig.25). 
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Two cases of PNET presented in 15 and 17 year old males respectively with an 
incidence of 1.87%. One presented in the nasal cavity and the other in the maxilla. 
Histopathology showed diffuse densely cellular sheets of uniform small to medium 
sized round cells with scant cytoplasm and round nuclei with delicate chromatin 
(Fig.26, Fig.27). 
One small round cell tumor diagnosed as SNEC presented in the nasal cavity of 
a 48 year old female. 
  Of the undiferentiated neoplasms 10 cases showed diffuse positivity for 
cytokeratin alone with focal positivity for NSE only in 2 cases with a final diagnosis 
of SNUC (Fig.32). 
5 tumors showed diffuse positivity for both cytokeratin and neuroendocrine 
markers namely NSE, synaptophysin confirming the diagnosis of SNEC (Fig.35, 
Fig.36). The incidence of  SNEC in the present study was 5.61%.There was a slight 
preponderance in males. Nasal cavity was the commonest site and peak age was found 
in 5
th
 decade similar to Silva et al (1982).
132
 Histopathology showed sheets of large 
round cells having moderate amount of cytoplasm,fine chromatin with inconspicuous 
nucleoli and focal rosette formation without fibrillary background (Fig.33, Fig.34). 
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CONCLUSION 
 
 
 
 
 
 
 
SUMMARY AND CONCLUSION 
Clinicopathological analysis of 200 neoplastic lesions of nasal cavity and 
paranasal sinuses was conducted. All the cases were classified according to WHO 
Head and neck tumors-2005. 
  Out of 200 cases, 93 were benign and 107 were malignant. Thus the incidence 
of malignant tumors outnumbered the benign tumors. Among all neoplastic 
lesions,squamous cell carcinoma (60 out of 200 cases) was the most frequent 
representing 30%. 
  144 were epithelial tumors and 56 were non epithelial tumors. Thus the 
incidence of epithelial tumors outnumbered the non epithelial tumors. 
Among benign tumors, inverted papilloma (40 out of 93 cases) was the 
common histological entity (43.01%). There was a slight higher incidence in males 
(62.5%).These tumors were seen mostly in the 5
th
 and 6
th
 decade. 
Hemangioma was the next common benign neoplastic lesion (27 out of 93) 
with an incidence of 29.03%.There was a male preponderance (66.66%). A higher 
incidence was noted in the 2
nd
 and 4
th
 decade. 
Among the malignant tumors, squamous cell carcinoma (60 out of 107 cases) 
was the most common (56.07%), the commonest site being nasal cavity. Mostly they 
presented as a mass lesion in the nose. The age incidence ranged from 3
rd
 to 9
th
 
decade. There was a male preponderance (73.33%). 
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Primary sinonasal tumors with neuroendocrine differentiation are an 
uncommon heterogenous group with overlapping histomorphological features. Based 
on their behaviour and natural history they can diverge in to two main groups namely 
esthesioneuroblastoma (ENB) and NonENB. They can be distinguished based on 
immunohistochemical characteristics. Pathological subcategorization is imperative for 
management and prognostication of these highly aggressive tumors. This 
categorization is based on the fact that excellent loco regional and distant control of 
ENB can be achieved with local therapy alone (surgery with or without postoperative 
local RT) where as SNUC and SNEC have higher rates of local and systemic failure 
and hence require aggressive multimodality approach including upfront 
chemotherapy. This study highlights the characteristics of the rare 6 cases of sinonasal 
neuroendocrine malignancies encountered and emphasizes the importance of IHC in 
distinguishing ENB from non ENB which has a bearing on prognosis and therapeutic 
intervention. 
Tumors of the nasal cavity and paranasal sinuses are rare pathologies with 
extremely varied etiopathology,clinical behaviour,treatment and prognosis. The 
symptoms of the neoplastic processes are essentially similar to inflammatory 
pathology of the sinonasal tract with resultant delay of diagnosis. The clinical and 
radiological features of masses of nasal cavity and paranasal sinuses are overlapping 
and often only a provisional diagnosis is possible. Definite diagnosis requires 
histopathological examination as most of the lesions are inaccessible for fine needle 
aspiration or FNAC is not recommended because of fear of haemorrhage. 
63
 
 
In our attempt at a comprehensive analysis of 200 sinonasal tumors a 
heterogenous and a wide variety of benign and malignant neoplasms were 
encountered. Rare entities like craniopharyngioma,schwannoma and osteoid osteoma 
among benign tumors and malignant melanoma,fibrosarcoma, metastatic clear cell 
carcinoma among malignant tumors were reported. 
To conclude, categorizing the sinonasal tumors according to histopathological 
features into various types helps us to understand the clinical presentation, treatment, 
clinical outcome and prognosis. The key in the diagnosis and treatment of sinonasal 
tumors remains a high index of suspicion and early diagnosis, as late presentation and 
delay in early diagnosis are major constraints to favourable outcome of treatment. 
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29 2484/07 22967 40 M R Maxilla  Mass Biopsy  Squamous cell Carcinoma  Mg Moderately 
Differentiated  
30 2596/07 26972 72 F L  Nasal cavity Mass Biopsy  Squamous cell carcinomna  Mg Well Differentiated  
31 2597/07 28589 49 M R Nasal cavity Mass Biopsy  Inverted Papilloma  Bn  
32 3446/07 36213 58 M L  Nasal cavity Mass Biopsy  Squamous Papilloma Bn  
33 3632/07 19194 30 M L  Nasal cavity Mass Biopsy  Squamous Papilloma Bn  
34 3664/07 37971 54 M R Nasal cavity Mass Biopsy  Melanoma Mg  
35 3771/07 35651 25 F R Ethmoid  Mass Biopsy  Mucoepidermoid Carcinoma  Mg High grade  
36 3874/07 18450 30 M R Nasal cavity Mass Biopsy  Inverted Papilloma Bn  
37 4506/07 18675 25 M L  Nasal cavity Mass Biopsy  Inverted Papilloma Bn  
38 4531/07 43843 36 F R Nasal cavity Mass Biopsy  Capillary Hemangioma Bn  
39 5038/07 57608 16 M R  Nasal cavity Mass Excision Biopsy  Capillary Hemangioma Bn  
40 5920/07 58888 46 M L  Nasal cavity Mass Biopsy  Adenocarcinoma Mg Well Differentiated  
41 6059/07 61214 65 M R Nasal cavity Mass Excision Biopsy  Hemangioendothelioma  Mg Low grade  
42 6898/07 65588 56 M L  Maxilla  Mass Maxillectomy  Squamous cell Carcinoma  Mg Moderately 
Differentiated  
43 6927/07 49894 50 M L  Nasal cavity Mass Excision Biopsy  Inverted Papilloma  Bn  
44 7576/07 44889 66 M R Nasal cavity Mass Biopsy  Plasmacytoma Mg  
45 7587/07 75652 29 M L  Nasal cavity Mass Excision Biopsy  Cavernous Hemangioma Bn  
46 7665/07 41361 50 M R Nasal cavity Mass Biopsy  Inverted Papilloma Bn  
47 7668/07 73472 17 M L  Frontal  Mass Excision Biopsy  Osteoid Osteoma  Bn  
48 7856/07 64034 46 M L  Maxilla  Mass Biopsy  Ameloblastoma- Follicular type  Bn  
49 8064/07 76447 49 F R Sphenoid Mass Biopsy  Mucoepidermoid Carcinoma  Mg High grade  
50 8086/07 76652 50 M R Nasal cavity Mass Biopsy  Inverted Papilloma with Malig 
Trans 
Mg  
51 8269/07 82014 65 M L  Nasal cavity Mass Excision Biopsy  Inverted Papilloma  Bn  
52 8339/07 21896 60 F R Nasal cavity Mass Excision Biopsy  Capillary Hemangioma Bn  
53 12/08. 85949 35 M R Sphenoid Mass, Headache, 
Blurring vision 
Biopsy  AdenoSquamous Carcinoma Mg High grade  
S. 
No 
Biopsy 
No  
IP/OP 
No 
           
Age 
sex Side  Site Complaints  Specimen Histologic Diagnosis Nature  Grade  
54 455/08 2094 67 M L  Nasal cavity Mass Biopsy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
55 497/08 4531 66 M R Nasal cavity Bleeding , Nasal 
obstruction  
Biopsy  Adenocarcinoma - Papillary type  Mg Moderately 
Differentiated  
56 584/08 4941 32 F R Nasal cavity Mass Biopsy  Adenoid cystic Carcinoma  Mg Grade II  
57 1301/08 5278 67 M L  Maxilla  Mass Maxillectomy  Ameloblastic Carcinoma  Mg  
58 1492/08 11959 34 F R  Nasal cavity Mass Excision Biopsy  Capillary Hemangioma Bn  
59 1541/08 13964 60 M R Nasal cavity Mass Biopsy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
60 2142/08 18958 45 F R Sphenoid Mass Biopsy  Metastasis from Clear cell 
carcinoma 
Mg  
61 2877/08 27990 33 M L  Nasal cavity Mass Excision Biopsy  Capillary Hemangioma  Bn  
62 3003/08 27998 40 M L  Nasal cavity Mass Excision Biopsy  Capillary Hemangioma  Bn  
63 3173/08 27408 60 M R Maxilla  Mass Maxillectomy   Acantholytic  Squamous cell 
carcinoma 
Mg Moderately 
Differentiated  
64 3394/08 32712 78 F L  Nasal cavity Mass Biopsy  Squamous cell carcinoma  Mg Well Differentiated  
65 3760/08 18686 65 F L  Maxilla  Mass Biopsy  Spindle cell Squamous cell 
carcinoma  
Mg High grade  
66 3869/08 33631 36 M L  Nasal cavity Mass Biopsy  Squamous cell carcinoma  Mg Poorly Differentiated  
67 3922/08 39259 29 F L  Nasal cavity Bleeding , Polyp Excision Biopsy  Inverted Papilloma  Bn  
68 4076/08 40398 48 F R Maxilla  Bleeding ,Nasal 
obstruction,Proptosis  
Maxillectomy  Hemangiopericytoma  Bn LMP 
69 4515/08 41604 39 M L  Nasal cavity Mass Biopsy  Squamous cell carcinoma  Mg Well Differentiated  
70 4163/08 42593 13 F R Nasal cavity Bleeding , Polyp Excision Biopsy  Capillary Hemangioma  Bn  
71 4290/08 41581 45 M L  Nasal cavity Bleeding , Polyp Excision Biopsy  Capillary Hemangioma  Bn  
72 4433/08 40398 48 F R Maxilla  Mass Maxillectomy  Hemangiopericytoma  Bn LMP  
73 4557/08 44340 85 M R Nasal cavity Mass Biopsy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
74 4866/08 25108 65 M L  Nasal cavity Mass Biopsy  Squamous cell carcinoma  Mg Well Differentiated  
75 5166/08 50349 65 M L  Nasal cavity Mass Excision Biopsy  Inverted Papilloma Bn  
76 5332/08 53712 52 F R Nasal cavity Mass Excision Biopsy  Inverted Papilloma  Bn  
77 5499/08 50349 65 M R Nasal cavity Mass Excision Biopsy  Inverted Papilloma  Bn  
78 5975/08 60694 57 M R Nasal cavity Mass Excision Biopsy  Inverted Papilloma Bn  
S. 
No 
Biopsy 
No  
IP/OP 
No 
           
Age 
sex Side  Site Complaints  Specimen Histologic Diagnosis Nature  Grade  
79 6041/08 62294 65 M L  Nasal cavity Mass Biopsy  Adenoid cystic Carcinoma  Mg Grade I  
80 6130/08 63600 20 M R  Nasal cavity Bleeding Polyp Excision Biopsy  Capillary Hemangioma Bn  
81 6185/08 892218 42 M R Nasal cavity Mass Biopsy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
82 6333/08 56374 60 F R Maxilla  Mass Maxillectomy  Squamous cell carcinoma  Mg Poorly Differentiated  
83 6707/08 849781 65 F L  Nasal cavity Mass Biopsy  Squamous cell carcinoma  Mg Poorly Differentiated  
84 7063/08 70905 45 M L  Maxilla  Mass Biopsy  Squamous cell carcinoma  Mg Well Differentiated  
85 7065/08 75643 61 M R Maxilla  Mass  Biopsy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
86 7285/08 71292 65 M L  Maxilla  Mass Maxillectomy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
87 7354/08 71218 22 M L  Ethmoid  Mass  Biopsy  Ossifying Fibroma  Bn  
88 7414/08 37333 60 M R Nasal cavity Mass, Epistaxis  Excision Biopsy  Capillary Hemangioma   Bn  
89 7578/08 25834 32 F L  Nasal cavity Mass Biopsy  Inverted Papilloma Bn  
90 7677/08 20943 67 M L  Maxilla  Mass Maxillectomy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
91 7707/08 35494 30 F R Nasal cavity Mass Excision Biopsy  Inverted Papilloma  Bn  
92 8105/08 86008 25 M L  Ethmoid  Polyp Excision Biopsy  Inverted Papilloma  Bn  
93 8134/08 84574 52 M L  Maxilla  Mass Biopsy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
94 8166/08 86053 58 M R Maxilla  Mass Biopsy  Squamous cell carcinoma  Mg Poorly Differentiated  
95 8322/08 88190 61 M R Maxilla  Polyp Excision Biopsy  Inverted Papilloma Bn  
96 8395/08 88848 30 F L  Nasal cavity Mass Excision Biopsy  Inverted Papilloma Bn  
97 8412/08 217441 70 F R Maxilla  Mass Biopsy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
98 8585/08 221196 60 F R Nasal cavity Mass Biopsy  Inverted Papilloma with Malig 
Trans 
Mg Well Differentiated  
99 8731/08 91998 48 M L  Frontal  Mass Biopsy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
100 8805/08 89594 70 F R Maxilla  Mass Maxillectomy  Squamous cell carcinoma  Mg Poorly Differentiated  
101 8844/08 93680 22 M L  Nasal cavity Mass Biopsy  Squamous Papilloma- Exophytic Bn  
102 118/09 36 26 M R Frontal  Mass Biopsy  Inverted Papilloma with Malig 
Trans 
Mg Well Differentiated  
103 217/09 2388 60 M L  Maxilla  Mass Biopsy  Squamous cell carcinoma  Mg Well Differentiated  
S. 
No 
Biopsy 
No  
IP/OP 
No 
           
Age 
sex Side  Site Complaints  Specimen Histologic Diagnosis Nature  Grade  
104 225/09 1858 65 M R Nasal cavity Mass Biopsy  Mucoepidermoid Carcinoma  Mg High grade  
105 497/09 2658 50 F L  Nasal cavity Mass Excision Biopsy  Capillary Hemangioma  Bn  
106 598/09 5831 40 F L  Maxilla  Mass Maxillectomy  Adenoid cystic Carcinoma  Mg Low grade  
107 892/09 11234 68 M L  Nasal cavity Mass Excision Biopsy  Papillary Adenocarcinoma  Mg Moderately 
Differentiated  
108 1030/09 7141 38 M L  Maxilla  Mass Maxillectomy  spindle cell sarcoma 
(Fibrosarcoma) 
Mg  
109 1294/09 14277 64 M R Nasal cavity Mass Excision Biopsy  Inverted Papilloma  Bn  
110 1357/09 15029 67 M L  Maxilla  Mass Biopsy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
111 2891/09 25773 30 F R Nasal cavity Mass Excision Biopsy  Schwannoma Bn  
112 2944/09 34580 33 F L  Nasal cavity Mass Excision Biopsy  Inverted Papilloma  Bn  
113 3520/09 36425 45 M L  Nasal cavity Mass Excision Biopsy  Inverted papilloma Bn  
114 3745/09 16665 50 F R Nasal cavity Polyp Excision Biopsy  Cavernous Hemangioma Bn  
115 3797/09 39235 2 F R Nasal cavity Polyp Excision Biopsy  Cavernous Hemangioma Bn  
116 4073/09 45583 45 M L  Maxilla  Mass Maxillectomy  Squamous cell Carcinoma  Mg Moderately 
Differentiated  
117 4230/09 45312 66 M L  Sphenoid Mass Biopsy  Adenocarcinoma - Papillary type  Mg Moderately 
Differentiated  
118 4490/09 50310 16 M R Nasal cavity Mass Biopsy  Capillary Hemangioma  Bn  
119 4792/09 56127 79 M L  Nasal cavity Mass Excision Biopsy  Inverted Papilloma Bn  
120 5069/09 26555 82 M L  Nasal cavity Polyp Excision Biopsy  Capillary Hemangioma Bn  
121 5085/09 23085 56 M R Nasal cavity Polyp Excision Biopsy  Inverted Papilloma Bn  
122 5188/09 60337 32 M L  Nasal cavity Mass Excision Biopsy  Capillary Hemangioma Bn  
123 5306/09 61708 24 M L  Nasal cavity mass Biopsy  Undifferentiated Carcinoma  Mg  
124 5618/09 65537 28 M L  Nasal cavity Mass Biopsy  Undifferentiated Carcinoma  Mg  
125 5800/09 60687 39 M R Nasal cavity Polyp Excision Biopsy  Schwannoma Bn  
126 5873/09 68223 80 F R Nasal cavity Mass Excision Biopsy  Inverted Papilloma Bn  
127 6322/09 68072 50 F R Nasal cavity Mass Excision Biopsy  Inverted Papilloma with Malig 
Trans 
Mg Well Differentiated  
128 7732/09 87197 41 F L  Nasal cavity Mass Biopsy  Inverted Papilloma Bn  
129 8102/09 90939 17 F L  Nasal cavity Mass Biopsy  Undifferentiated Carcinoma  Mg  
130 8117/09 40753 41 F L  Nasal cavity Mass Biopsy  Adenoid cystic Carcinoma  Mg Low grade  
S. 
No 
Biopsy 
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IP/OP 
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Age 
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131 8292/09 88714 62 M R Nasal cavity Mass Biopsy  Adenoid cystic Carcinoma  Mg Low grade  
132 8501/09 87218 41 F R Nasal cavity Mass Excision Biopsy  Inverted Papilloma Bn  
133 8634/09 51188 67 M L  Maxilla  Mass, Proptosis  Biopsy  Schwannoma Bn  
134 8784/09 57598 60 M L  Nasal cavity mass Excision Biopsy  Inverted Papilloma  Bn  
135 8827/09 42865 50 F R Maxilla  Mass Biopsy  Undifferentiated Carcinoma  Mg  
136 159/10 102667 52 M R Nasal cavity Polyp Excision Biopsy  Inverted Papilloma with Malig 
Trans 
Mg Well Differentiated  
137 188/10 102882 50 M R Nasal cavity Mass Excision Biopsy  Squamous cell Carcinoma  Mg Well Differentiated  
138 247/10 607125 60 M L  Nasal cavity Mass Biopsy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
139 419/10 5178 62 M R Nasal cavity Mass Excision Biopsy  Inverted Papilloma Bn  
140 474/10 2605 42 F R Nasal cavity Mass Biopsy  Small round cell tumour Mg  
141 482/10 6519 60 M R Nasal cavity Mass Biopsy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
142 520/10 6849 25 M L  Nasal cavity Polyp Excision Biopsy  Papilloma- Oncocytic Bn  
143 682/10 9141 42 M L  Nasal cavity Mass Excision Biopsy  Inverted Papilloma Bn  
144 725/10 9242 65 M L  Nasal cavity Mass Excision Biopsy  Inverted Papilloma Bn  
145 993/10 51854 19 M L  Nasal cavity Bleeding Polyp Excision Biopsy  Hemangiopericytoma  Bn LMP 
146 1094/10 11194 70 M L  Maxilla  Mass Biopsy  Undifferentiated Carcinoma  Mg  
147 1371/10 16005 29 M R Nasal cavity Polyp Excision Biopsy  Capillary Hemangioma  Bn  
148 1478/10 10345 17 M L  Maxilla  Mass Biopsy  Small round cell tumour Mg  
149 1647/10 19044 60 M R Nasal cavity Mass Biopsy  Inverted Papilloma with Malig 
Trans 
Mg Well Differentiated  
150 1666/10 17011 42 M R Nasal cavity Mass Excision Biopsy  Schwannoma Bn  
151 1683/10 17210 15 M L Nasal cavity Mass Biopsy  Small round cell tumour Mg  
152 3078/10 34363 65 M L  Nasal cavity Mass Excision Biopsy  Capillary Hemangioma Bn  
153 3430/10 27506 40 F L  Maxilla  Mass Biopsy  Adenoid cystic Carcinoma  Mg Grade II  
154 3562/10 448800 45 M L  Nasal cavity Mass Biopsy  Undifferentiated Carcinoma  Mg  
155 4303/10 22634 50 F R Nasal cavity Mass, Epistaxis  Biopsy  Hemangiopericytoma  Bn LMP 
156 4494/10 48199 51 F L  Nasal cavity Mass, Epistaxis  Biopsy  Hemangiopericytoma  Bn LMP 
157 4728/10 50542 70 M L  Nasal cavity Mass Biopsy  Adenoid cystic Carcinoma  Mg Grade II  
158 4790/10 51080 34 M R Maxilla  Mass Biopsy  Undifferentiated Carcinoma  Mg  
S. 
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159 4810/10 57131 65 M R Nasal cavity Mass Biopsy  Squamous cell carcinoma  Mg Poorly Differentiated  
160 5201/10 48199 51 F R Nasal cavity Mass Biopsy  Hemangiopericytoma  Bn LMP  
161 5224/10 57097 31 M L  Nasal cavity Mass, epistaxis, 
Obstruction  
Biopsy  Undifferentiated Carcinoma  Mg  
162 5761/10 62461 41 F R Nasal cavity Mass Biopsy  Inverted Papilloma  Bn  
163 5849/10 61401 60 M R Nasal cavity Mass Excision Biopsy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
164 5976/10 64935 40 F R Nasal cavity Mass, epistaxis Biopsy  Undifferentiated Carcinoma  Mg  
165 6225/10 67414 18 M R  Nasal cavity Mass Biopsy  Craniopharyngioma Bn  
166 7304/10 48795 51 M R Maxilla  Mass Biopsy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
167 8138/10 41204 20 F R Ethmoid  Mass, Proptosis  Biopsy  Olfactory neuroblastoma Mg  
168 8516/10 94816 63 M R Nasal cavity Mass Biopsy  Inverted Papilloma with Malig 
Trans 
Mg Moderately 
Differentiated  
169 8632/10 95464 60 M R Nasal cavity Mass Excision Biopsy  Capillary Hemangioma Bn  
170 8633/10 94802 30 F L  Nasal cavity Mass, epistaxis Excision Biopsy  Capillary Hemangioma Bn  
171 423/11 327 31 M R Nasal cavity Mass Biopsy  Undifferentiated Carcinoma  Mg   
172 440/11 6054 71 M L  Nasal cavity Mass Biopsy  Squamous cell carcinoma  Mg Poorly Differentiated  
173 459/11 1975 40 M R Maxilla  Mass Maxillectomy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
174 951/11 9875 32 M R Nasal cavity Mass Biopsy  Psammomatoid Ossifying Fibroma  Bn  
175 1643/11 19679 32 M R Nasal cavity Mass, epistaxis  Excision Biopsy  Psammomatoid Ossifying Fibroma  Bn  
176 1908/11 32711 40 F L  Nasal cavity Mass Excision Biopsy  Schwannoma Bn  
177 2323/11 27409 17 M R Nasal cavity Mass Excision Biopsy  Capillary Hemangioma Bn  
178 3370/11 36489 65 M R Nasal cavity Mass Biopsy  Inverted Papilloma Bn  
179 3373/11 35681 13 F R Nasal cavity Mass Biopsy  Inverted Papilloma Bn  
180 3540/11 39969 48 M R Nasal cavity Mass Excision Biopsy  Undifferentiated Carcinoma  Mg  
181 3697/11 35240 60 M R Nasal cavity Mass Biopsy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
182 3792/11 40313 45 F L  Sphenoid Mass Biopsy  Squamous cell carcinoma  Mg Poorly Differentiated  
183 3863/11 39489 65 F L  Nasal cavity Mass Biopsy  Inverted Papilloma Bn  
184 5282/11 57629 42 M L  Ethmoid  Mass Biopsy  Adenocarcinoma-(colonic type) Mg Well Differentiated  
185 5407/11 61485 48 M L  Nasal cavity mass Biopsy  Olfactory neuroblastoma Mg  
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186 5561/11 62893 62 M R Nasal cavity Mass Biopsy  Undifferentiated Carcinoma  Mg  
187 5563/11 61370 72 M L  Nasal cavity Bleeding Polyp Excision Biopsy  Capillary Hemangioma Bn  
188 6046/11 66195 45 M R Maxilla  Mass Biopsy  Squamous cell carcinoma  Mg Well Differentiated  
189 6199/11 57999 38 M L  Sphenoid Mass Excision Biopsy  Capillary Hemangioma Bn  
190 6303/11 70491 32 M R Nasal cavity mass Excision Biopsy  Ameloblastoma Bn  
191  
6512/11 
73167 13 F R Maxilla  Nasal Obstruction Biopsy  Cemento ossifying Fibroma Bn  
192 7379/11 83747 65 F L  Nasal cavity Mass Biopsy  Inverted Papilloma Bn  
193 7736/11 86561 50 M L  Nasal cavity Mass Biopsy  Inverted Papilloma Bn  
194 7791/11 89344 46 M R Nasal cavity Mass Biopsy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
195 7793/11 82882 63 F L  Nasal cavity Mass, epistaxis Excision Biopsy  Inverted Papilloma Bn  
196 8113/11 85344 48 M R Nasal cavity Mass Biopsy  Undifferentiated Carcinoma  Mg  
197 8155/11 86851 50 M L Nasal cavity Mass Excision Biopsy  Capillary hemangioma Bn  
198 8161/11 88571 53 F L Maxilla  Mass Maxillectomy  Squamous cell carcinoma  Mg Moderately 
Differentiated  
199 8367/11 90440 40 M L  Nasal cavity Mass Biopsy  Melanoma Mg  
200 8507/11 94626 50 F R Nasal cavity Mass Biopsy  Plasmacytoma Mg  
 
KEY TO MASTER CHART 
 
Bn- Benign 
Mg-Malignant 
M - Male 
F  - Female  
R-  Right 
L-  Left 
LMP- Low Malignant Potential  
Inverted papilloma with Malig Trans- Inverted papilloma with malignant 
transformation 
  
 
 
 
 
 
 
 
 
 
ANNEXURES 
 ANNEXURE - I 
IMMUNOHISTOCHEMISTRY PANEL 
S. 
No 
Biopsy No 
HPE 
Diagnosis 
IHC Markers 
Final 
Diagnosis 
   CK 
Synapto
physin 
NSE Vimentin CD45 Desmin 
HMB 
45 
S100 CD99  
1 1264/07 UDC 
Focal 
+ 
+ + - - - - - - SNEC 
2 1918/07 UDC 
Focal 
+ 
+ + - - - - - - SNEC 
3 3667/07 Melanoma - - - + - - + + - Melanoma 
4 5306/09 UDC + - - - - - - - - SNUC 
5 8102/09 UDC + - - - - - - - - SNUC 
6 8827/09 UDC + - Focal + - - - - - - 
SNUC with 
focal NE 
7 1030/09 
Spindle cell 
sarcoma 
- - - + - - - - - 
Fibrosarco
ma 
8 474/10 SRCT 
Focal 
+ 
+ + - - - - - - SNEC 
9 1094/10 UDC + - - - - - - - - SNUC 
10 1478/10 SRCT - - - + - - - - + PNET 
11 1683/10 SRCT - - - - - - - - + PNET 
12 3562/10 UDC 
Focal 
+ 
- - - - - - - - SNUC 
13 4790/10 UDC 
Focal 
+ 
- - - - - - - - SNUC 
14 5224/10 UDC 
Focal 
+ 
- - - - - - - - SNUC 
15 5976/10 UDC + + Focal+ - - - - - - SNEC 
16 8138/10 ONB 
Focal 
+ 
+ + - - - - + - ONB 
17 423/11 UDC + Focal + + - - - - - - SNEC 
18 3540/11 UDC + - - - - - - - - SNUC 
19 5407/11 ONB 
Focal 
+ 
+ + - - - - + - ONB 
20 5561/11 UDC + - Focal + - - - - - - 
SNUC with 
Focal NE 
21 5618/11 UDC + - - - - - - - - SNUC 
22 8113/11 UDC 
Focal 
+ 
Focal + + - - - - - - SNEC 
23 8367/11 Melanoma - - - + - - + + - Melanoma 
ANNEXURE - II 
 
PATIENT PROFORMA 
NAME: 
AGE: 
OP/IP NO: 
CLINICAL PRESENTATION: 
PATHOLOGY ID NO: 
LOCATION OF TUMOUR              
             Nasal cavity 
               Maxillary sinus 
               Ethmoid sinus 
               Frontal sinus 
   Sphenoid sinus 
LATERALITY OF PRESENTATION: RIGHT/LEFT 
HISTOLOGIC DIAGNOSIS:   BENIGN/MALIGNANT 
                                                   GRADE  

ABSTRACT 
CLINICO PATHOLOGICAL PROFILE OF SINO NASAL TUMORS – A FIVE 
YEAR STUDY 
BACKGROUND: The nasal cavity and the paranasal sinuses form a single functional 
unit. Sinonasal tumours are characterized by low incidence, non specific symptoms, 
and late presentation. The sinonasal tumours encompass an entire range of both 
epithelial and non-epithelial tumours. Undifferentiated malignant neoplasms of the 
sinonasal tract are clinically aggressive and share clinical and light microscopic 
features. Immunohistochemistry might be of immense help for pathological 
subcategorization of these highly aggressive tumors which is imperative for 
management and prognostication. 
 
AIMS & OBJECTIVES: The present study aims to determine incidence, age, sex, 
site, mode of presentation and histological types of various sinonasal tumours over a 5 
year period and the importance of immunohistochemistry in undifferentiated 
malignant neoplasms of the sinonasal tract. 
 
METHODS: 200 sinonasal tumors biopsied or surgically excised over a period from 
Janauary 2007 to October 2011 were studied. The tumors were classified as benign or 
malignant according to WHO classification. A panel of immunohistochemical markers 
including Cytokeratin, Synaptophysin, Neuron specific enolase, CD99, vimentin, 
CD45, Desmin, S100, HMB45 were employed for the undifferentiated malignant 
neoplasms and small round cell tumors. 
RESULTS: The incidence of sinonasal tumors was 0.45%. Among the 200 tumors 
studied, 107 (53.5%) were malignant lesions and 93 (46.5%) were benign lesions. All 
age groups were involved with a mean age of 42.5 years for benign tumors and 52.05 
years for malignant tumors. The male to female ratio was 1.7:1 for benign tumors and 
2.3:1 for malignant tumors. The maximum number of cases were present in the nasal 
cavity (70%). Inverted papilloma was the commonest benign tumor and Squamous 
cell carcinoma was the commonest malignant tumor. Epithelial tumors (72%) 
outnumbered nonepithelial tumors (28%). The most common mode of presentation 
was nasal mass. 
 CONCLUSION: The clinical and radiological features of masses of nasal cavity and 
paranasal sinuses are overlapping and often only a provisional diagnosis is possible. 
Definite diagnosis requires histopathological examination. Immunohistochemistry is 
mandatory for Pathological subcategorization of undifferentiated malignant neoplasms 
of the sinonasal tract. 
 
 KEY WORDS:Nasal cavity, paranasal sinuses, Tumors, Immunohistochemistry 
